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Abstract 
The primary goal of immunology is to maximize the immune system’s potential 
to control or eliminate harmful infection. This can be achieved through vaccination, 
though current vaccine strategies have had limited success when targeting CD4+ T cell-
dependent cellular immunity to intracellular infections. CD4+ T cells are cells of the 
adaptive immune system that use clonally-distributed T cell antigen receptors (TCRs) to 
recognize 9 amino acid peptide antigens bound to Major Histocompatibility Complex II 
(MHCII) molecules on host cells. Each vertebrate animal contains a large set of CD4+ T 
cells, each with a unique TCR and generated before infection. Here, we studied the 
repertoire of CD4+ T cells in mice to better understand why some non-mouse (foreign) 
peptide:MHCII ligands (p:MHCII) stimulate stronger immune response than others. We 
found that naïve CD4+ T cell populations specific for different foreign p:MHCII vary 
considerably in size and that large naïve populations produce more effector cells during 
an immune response than small ones. Because the T cell repertoire in a mouse is 
generated by removal in the thymus of clones with TCRs that recognize mouse p:MHCII, 
we tested the possibility that the size of a given naïve foreign peptide-specific T cell 
population is shaped by negative selection on similar mouse (self) peptides. We found 
that identity at 4 amino acid positions was all that was required for two MHCII-binding 
nonamer peptides to bind the same TCR. This basic principle allowed in silico 
approaches to reveal that the number of cells in a foreign peptide-specific T cell 
population was inversely related to the number of MHCII-binding self peptides with the 
same 4 TCR contact amino acids. Therefore, the size of a given naïve foreign p:MHCII-
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specific T cell population is shaped by negative selection due to TCR cross-reaction on 
similar self p:MHCII ligands.  
We next explored the effect of a large foreign p:MHCII-specific T cell population 
on immunity. Because CD4+ T cells protect hosts from infections that have evolved to 
persist in the phagosomes of infected cells, it was of interest to test this issue during a 
persistent Salmonella enterica serovar Typhimurium (ST) infection. Remarkably, I found 
that this one large foreign p:MHCII-specific T cell population played a large role in 
controlling ST infection, despite the likely presentation of many other ST-derived 
p:MHCII. This control was associated with numerical and functional stability of the large 
foreign p:MHCII-specific T cell population for greater than a year after oral infection. 
This stability was associated with peptide:MHCII-driven proliferation by a small number 
of T cells in the secondary lymphoid organs that harbored bacteria. Thus, my work could 
instruct novel subunit vaccine strategies to target large naïve CD4+ T cell populations and 
maintain their responses with longer-lasting peptide delivery. 
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Chapter 1 
 
Background and Introduction 
 
Immunology began as a scientific discipline with major implications for human 
health when Edward Jenner demonstrated that inoculation with the infectious material of 
cowpox could protect against acquisition of the human disease smallpox. He termed this 
procedure vaccination. Many years later, it was discovered that microbes are the 
infectious causes of transmissible diseases. Louis Pasteur developed methods to isolate 
infectious microbes, inactivate them, and inject them. These principles led to effective 
vaccines against many deadly human diseases, including polio, measles, mumps, rubella, 
diphtheria, and tetanus. Today, vaccination has saved more lives than any other medical 
intervention.  
It is now appreciated that the vaccine approach originally described by Pasteur 
successfully produces humoral immunity to extracellular pathogens. This is due to the 
fact that transient antigen exposure is sufficient to generate long-lived plasma cells that 
can produce neutralizing antibodies (Slifka, Antia et al. 1998). For intracellular 
infections, such as Mycobacterium tuberculosis, Leishmania major, and Salmonella 
enterica, however, the classical approach to vaccinology has failed because antibodies 
cannot eliminate microbes that persist within the phagosomes of phagocytes (Tubo and 
Jenkins 2014). CD4+ T cells are the critical cell type for immune protection from these 
types of infections (Erb, Blank et al. 1996, Scanga, Mohan et al. 2000, Mogues, Goodrich 
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et al. 2001, Reith and Mach 2001). Therefore, a deeper understanding of the factors that 
create robust and long-lived CD4+ T cell-mediated immunity will be necessary to create 
new classes of vaccines to target these important human pathogens (Sette and Rappuoli 
2010). 
 
Adaptive immunity and the Clonal Selection Theory  
The clonal selection theory of acquired immunity was proposed by Sir 
MacFarlane Burnet in the 1950s and was the first comprehensive explanation for how the 
adaptive immune system responds to foreign antigens. Burnet correctly suggested that 
individual cells, or clones, each express a unique receptor that determines its specificity. 
Clones that express receptors with affinity for self antigens are deleted at an early stage 
of development (clonal deletion). Mature clones that bind cognate antigen through their 
unique receptor undergo cell activation and division (clonal expansion) and the progeny 
of a divided cells bear receptors of the same specificity as the parental cells (Burnet 
1959). Remarkably, this description of the key principles of the adaptive immune system 
occurred before lymphocytes were even discovered as the responsible cells (Gowans, 
McGregor et al. 1962). Thus, while many important details have been added, such as the 
mechanism for diversification of antigen receptors (Tonegawa, Steinberg et al. 1974, 
Schatz, Oettinger et al. 1989), clonal selection remains the guiding principle for studying 
the adaptive immune system. 
 
Generation and selection of TCR diversity during thymic development  
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Burnet’s clonal selection theory predicted that each lymphocyte would have a 
unique receptor and that receptors with affinity for self antigens would be deleted at an 
early stage of development. Many details of this process for T cells are now clear. CD4+ 
and CD8+ T cells are generated from hematopoietic progenitors that migrate from the 
bone marrow to the thymus. Progenitor cells enter the thymus through the bloodstream, 
proliferate, and pass through a series of developmental stages before exiting back to the 
blood and secondary lymphoid organs. TCR diversity is established by somatic 
recombination of gene segments encoded by TCRα and TCRβ gene loci (Nikolich-
Zugich, Slifka et al. 2004). This process occurs independently in a random fashion in 
each developing T cell clone. Variable, Diverse, and Joining (VDJ) gene segments are 
flanked by 12 and 23 base pair recombination signal sequence (RSS) motifs that are 
recognized by a complex of enzymes known as the V(D)J recombinase. Lymphocyte-
specific expression of the RAG1 and RAG2 enzymes within the recombinase cleaves 
DNA at RSS sites to create sites for joining the coding ends of V, D, and J segments. 
Non-templated stretches of nucleotides are added by the enzyme terminal 
deoxynucleotidyl transferase (TdT), and the gene segments are recombined. This occurs 
in a stepwise process in each developing T cell clone to produce functional TCRα and 
TCRβ genes. The multiple combinations of gene pairs and junctional diversities created 
by this process can produce a theoretical repertoire of 1015 unique TCRs in mice and 1018 
in humans (Davis 1990). Thus, the process ensures a highly diverse set of clonally 
distributed T cell receptors (TCRs) that are collectively capable of recognizing a vast 
number of p:MHC antigens. 
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Rearranged TCRs are expressed on the cell surface as αβ heterodimers and 
determine the fate of each clone during subsequent thymic selection. Double positive 
(DP) thymocytes, characterized by expression of both CD4 and CD8 co-receptors, 
undergo positive selection if their TCRs are capable of reacting with self peptides and 
MHC molecules presented by cortical epithelial cells (cTECs) (Jameson, Hogquist et al. 
1995). Most clones undergo death by neglect, a form of programmed cell death, however 
DP thymocytes that recognize self p:MHCII survive and further differentiate into CD4 
single positive (CD4SP) cells (Singer, Adoro et al. 2008). CD4SPs then migrate to the 
medulla, where they undergo negative selection on ubiquitous and tissue-restricted self 
p:MHCII expressed by thymic dendritic cells (DCs) and medullary thymic epithelial cells 
(mTECs) (Anderson, Venanzi et al. 2002, Klein, Kyewski et al. 2014). Thymocytes 
expressing TCRs with a high affinity for self p:MHCII expressed by DCs and mTECs 
undergo apoptosis or become FoxP3+ T regulatory cells (Klein, Kyewski et al. 2014). 
Thus, only T cells with a narrow range of reactivity to self p:MHCII survive positive and 
negative selection in the thymus.  
 
p:MHCII recognition by CD4+ T cells  
Knowledge of p:MHC presentation is necessary for determining the critical 
aspects of TCR recognition. MHCII molecules are expressed on the surface of antigen 
presenting cells (APCs) such as macrophages and DCs, which take up extracellular 
proteins by phagocytosis or macropinocytosis. Internalized proteins are 
compartmentalized and subjected to proteolytic cleavage by enzymes such as cathepsins. 
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The resulting peptides that are capable of binding MHCII are transported to the cell 
surface.  
The open-ended structure of MHCII peptide binding grooves permits binding and 
presentation of peptides from 9-25 amino acids in length (Chicz, Urban et al. 1992, Hunt, 
Michel et al. 1992). As a result, determining the relevant MHCII binding register, or core 
nonamer peptide for CD4+ TCR recognition, has been a difficult problem (Wang, Sidney 
et al. 2008, Chaves, Lee et al. 2012). A solution to this problem has been to combine 
information gathered from individual p:MHCII crystal structures (Painter and Stern 2012) 
with peptide elution studies (Falk, Rotzschke et al. 1991, Zhu, Rudensky et al. 2003). 
This information has been used to generate effective computational methods for 
predicting peptides that will bind to a multiple MHCII allelomorphs based upon the 
presence of key MHCII anchor residues within the peptide (Chaves, Lee et al. 2012). 
TCRs bind p:MHC through 6 complementary determining region (CDR) loops: 
CDR1α, CDR1β, CDR2α, CDR2β, CDR3α, and CDR3β. The CDR1 and CDR2 loops 
consist of germline encoded V regions that bind to conserved regions of MHC molecules 
(Marrack, Scott-Browne et al. 2008). These interactions explain the inherent MHC 
reactivity of highly diverse TCRs. They can also account for the common diagonal 
docking angle of TCRs with respect to the axis of the MHC peptide binding groove 
(Rudolph, Stanfield et al. 2006). This orients the CDR3, or hypervariable, loops of the 
alpha and beta chains over the MHC-bound peptide to confer TCR specificity. The 
affinities of TCRs for p:MHC is typically in the 1-100 µM range (Davis 1998). Thus, this 
interaction is thought to be relatively low affinity but highly specific. More recent 
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evidence presented below, however, suggests that TCRs may be highly cross-reactive for 
multiple different p:MHC. 
 
The pre-immune T cell repertoire  
The pre-immune repertoire, or naïve repertoire, consists of millions cells that have 
exited the thymus but never encountered a foreign p:MHCII agonistic ligand. CD4+ T 
cells predominantly exist in a naïve or quiescent state until encountering cognate 
p:MHCII through their TCR. Naïve T cells in mice are marked by low expression of the 
cell surface marker CD44 and express the trafficking molecules L-selectin (CD62L) and 
CCR7, which allow them to enter lymphatic tissues via high endothelial venules and 
migrate along a CCL19 and CCL21 chemokine gradient. 
The mouse repertoire has an estimated 2x106 different αβ TCR clonotypes and 
the human repertoire contains approximately 10 times more (Arstila, Casrouge et al. 
1999, Casrouge, Beaudoing et al. 2000). A completely naïve repertoire would only persist 
under completely antigen-free conditions. Under specific pathogen free (SPF) conditions, 
the mouse repertoire contains approximately 70% naïve phenotype cells, 10% recent 
thymic immigrants, 10% memory phenotype cells, and 10% FoxP3+ natural T regulatory 
cells (Jenkins, Chu et al. 2010). However, it has recently been shown that the ratio of 
circulating memory cells to naïve cells is higher in humans than the commonly studied 
SPF mice. This is true for even p:MHCII-specific populations of cells that recognize 
foreign peptides to which the host has not been exposed, suggesting TCR cross-reactivity 
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for environmental microbes could alter the “pre-immune” repertoire in ways not yet 
known (Su, Kidd et al. 2013).  
 
Immunodominance 
Although a pathogen can theoretically express thousands of peptides during 
infection, only a fraction of peptides induce robust immune responses. This concept is 
referred to as immunodominance. Predicting immunodominant T cell responses has been 
the focus of considerable efforts and it is now clear that numerous factors contribute to 
this phenomenon. The amount and duration of p:MHCII antigen presentation are CD4+ T 
cell extrinsic signals that affect clonal expansion and differentiation (Itano, McSorley et 
al. 2003, Obst, van Santen et al. 2005, Prlic, Hernandez-Hoyos et al. 2006, Henrickson, 
Mempel et al. 2008, Tubo, Pagan et al. 2013). Foreign protein expression levels and 
location, APC proteolysis, and MHCII binding stability dictate the amount of p:MHCII 
produced, and thus the strength of these signals (Sant, Chaves et al. 2005, Yewdell 2006). 
The composition of the naïve T cell repertoire also shapes immunodominance. Evidence 
for this comes from studies utilizing p:MHC tetramer-based cell enrichment methods to 
quantify rare, polyclonal p:MHC-specific CD4+ and CD8+ T cells in both unexposed and 
antigen-experienced subjects. This work has demonstrated that the number of naïve cells 
in the naïve repertoire is perhaps the most critical predictor of immunodominant T cell 
responses (Moon, Chu et al. 2007, Kotturi, Scott et al. 2008, Obar, Khanna et al. 2008, 
Flesch, Woo et al. 2010, Schmidt, Neumann-Haefelin et al. 2011, Tan, La Gruta et al. 
2011, Kwok, Tan et al. 2012).  
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Statement of thesis 
This thesis focuses on how foreign p:MHCII-specific CD4+ T cell populations are 
generated as naïve cells and maintained as memory cells following infection. A p:MHCII 
tetramer-based cell enrichment strategy was employed to demonstrate that TCR cross-
reactivity for different MHCII-bound peptides is largely dependent upon amino acids at 
TCR contact positions, that the sizes of naïve CD4+ T cell populations recognizing 
foreign pMHCII ligands is influenced by TCR cross-reactivity with MHCII-binding self 
peptides, and that prolonged foreign p:MHCII presentation maintains CD4+ T cell 
stability and function following infection. This work is significant because there are no 
current vaccines that successfully target and sustain long lasting CD4+ T cell-mediated 
immunity. 
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Chapter 2 
Materials and Methods 
 
Mice 
C57BL/6 (B6), B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice, and 129SvJ (129) female mice 
were purchased from the Jackson labs. Act-2W, (B6 x 129) F1, (CD45.1 x 129) F1, and 
(Act-2W x 129) F1 mice were bred in our facilities. All mice were housed in specific 
pathogen-free conditions at the University of Minnesota and all experiments were 
conducted in accordance with institutional and federal guidelines.  
 
Plasmid construction 
Sequences encoding pRMHa-3 vectors containing the α- and β-chains of I-Ab under the 
control of the metallothionein promoter were constructed as described in Moon et al. 
(Moon, Chu et al. 2007). Sequences encoding antigenic peptides (ESAT6: 
QQWNFAGIEAAASA (Reiley, Shafiani et al. 2010); FliC: VQNRFNSAITNLGNT 
(Moon, Chu et al. 2007); STM1540-3: VYYTTYAPQAT; STM1540-1: 
YTTYAPQATSA; eGFP: HDFFKSAMPEGYVQE; OVA3C: GHAAHAEINEAG 
(Robertson, Jensen et al. 2000, Moon, Dash et al. 2011); RpIF: VFVSPAAHIID (Li and 
McSorley 2013); OVA2C: QAVHAAHAEIN (Robertson, Jensen et al. 2000, Moon, 
Dash et al. 2011); 3K: EAQKAKANKAVDKA; Calnex: LVVKNPAAHHAIS; Aasf: 
GVSSPAVQESI (Li and McSorley 2013); 1G1W: EAGGALANWAVDSA (Chu, Moon 
et al. 2010); LLO: NEKYAQAYPNVS (Geginat, Schenk et al. 2001); Derp1: 
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CQIYPPNVNKI; MP98: HQYMTALSNEVVF; PmpG-1: YVDPAAAGG (Li and 
McSorley 2013); CTB: NNKTPHAIAAIS (Cong, Bowdon et al. 1996); GP66: 
DIYKGVYQFKSV (Oxenius, Bachmann et al. 1995, Moon, Dash et al. 2011); 2W: 
EAWGALANWAVDSA; CD4Ag28m: VEIHRPVPGTA (Grover, Blanchard et al. 
2012); 2W109: EYWGPLPNWVVD; and MOG: GWYRSPFSRVV were fused to the N 
terminus of the I-Ab β-chain via a flexible polyglycine linker. For LLO:I-Ab, OVA2C:I-
Ab, OVA3C:I-Ab, STM1540-3:I-Ab, STM1540-1:I-Ab, 2W109:I-Ab, and MOG:I-Ab 
tetramers, a disulfide trap strategy was used to prevent peptide movement within the 
MHCII groove and lock in the desired peptide binding register, as previously described 
(Stadinski, Zhang et al. 2010, Moon, Dash et al. 2011).  
 
p:MHCII tetramer production  
Tetramers were designed produced in the Jenkins lab and by collaborators (Li and 
McSorley 2013). Peptide:I-Ab molecules were expressed in Drosophila melanogaster S2 
cells using the Drosophila Expression System kit (Invitrogen, Carlsbad, CA). The soluble 
p:I-Ab heterodimers were then purified from the cell culture supernatant via nickel 
affinity chromatography as previously described (Moon, Chu et al. 2007), followed by an 
additional purification on a Pierce Monomeric Avidin UltraLink Resin (Thermo 
Scientific, Rockford, IL, USA). The biotinylated p:I-Ab molecules were eluted with free 
biotin and washed using Amicon Ultra-15 30kD concentrating filters (Merck Millipore 
Ltd., Tullagreen, Carrigtwohill Co. Cork, IRL) to remove excess free biotin. The 
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resulting product was then used to generate tetramers with streptavidin (SA)-
phycoerythrin (PE) or (SA)-allophycocyanin (APC) (Prozyme, San Leandro, CA, USA). 
 
Cell enrichment and flow cytometry 
Chapter 3: Spleen and lymph node cells were harvested and made into single cell 
suspensions. Tetramer staining was for 1 hour at room temperature with p:I-Ab-
streptavidin-PE and p:I-Ab-streptavidin-APC tetramers. Anti-PE and anti-APC magnetic 
beads were then incubated on ice and the samples were enriched for bead-bound cells as 
previously described (Moon, Chu et al. 2007, Tubo, Pagan et al. 2013). Cells contained 
within the bound fraction were stained on ice with antibodies specific for the cell surface 
markers B220 (RA3-6B2), CD11b (MI-70), CD11c (N418), Thy1.2 (53-2.1), CD8a 
(5H10; Invitrogen, Carlsbad, CA, USA), CD4 (RM4-5), CD3ε (145-2C11), and CD44 
(IM7), each conjugated to a different fluorochrome. All antibodies were from 
eBioscience (San Diego) unless noted. Cells were then analyzed on an LSR II or Fortessa 
(Becton Dickinson) flow cytometer. Data were analyzed with FlowJo (TreeStar, Ashland, 
OR, USA).  
Chapter 4: Spleen and lymph node cells were harvested and made into single cell 
suspensions. 10% of the cell suspensions was removed for plating bacterial CFUs with 
the addition of 0.1% Triton. The remaining 90% of the samples were stained for 1 hour at 
room temperature with or 2W:I-Ab-streptavidin-APC tetramer, enriched for tetramer 
bound cells, counted and labeled with antibodies as previously described (Moon, Chu et 
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al. 2007). Cells events were collected on an LSRII or Fortessa flow cytometer (Becton 
Dickinson) and analyzed using FlowJo software (TreeStar). 
 
Peptide immunization  
Peptides were dissolved in PBS and emulsified in Complete Freund’s Adjuvant (CFA). 
Fifty microliters of emulsion containing a final concentration of 10 µg peptide was 
injected subcutaneously at the base of the tail.  
 
PSSM 
A position-specific scoring matrix (PSSM) for I-Ab binding was generated by using the I-
Ab binding motif described by Zhu et al. to (Zhu, Rudensky et al. 2003) to align an 
additional 128 I-Ab-bound peptides (Dongre, Kovats et al. 2001, Karunakaran, Rey-
Ladino et al. 2008). 
 
ELISPOT 
Mice were immunized by injection of 10 µg peptide emulsified in CFA, as described 
above. Two weeks later, CD4+ T cells were isolated from the draining inguinal and para-
aortic lymph nodes and purified using positive selection with anti-CD4 magnetic beads 
(Miltenyi). The cells were challenged with candidate peptides in vitro at a final 
concentration of 20 µM and analyzed for the presence of IFNγ-producing CD4+ T cells 
by ELISPOT. The ELISPOT assay was adapted from a published protocol (Streeck, 
Frahm et al. 2009) and assay guidelines from a commercially available kit (Mabtech). 
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Individual wells (peptides) were performed in triplicate. Each sample of cells included 
negative controls consisting of un-stimulated cells as well as cells stimulated with an 
irrelevant peptide. Positive controls included cells stimulated with ConA. 
 
Alanine scanning approach 
Alanine substitutions were made at P-1 to P10 for 14 foreign peptides. In places where A 
was in the native sequence, V was substituted, with the exception of P4 or P6, where P 
was substituted. This was to avoid shifting the I-Ab-binding register because P is the 
preferred amino acid at P4 and P6 based on a peptide-I:Ab-binding matrix. The peptides 
were tested as stimulators of a secondary in vitro response of bulk lymph node cells 
primed with peptide emulsified in CFA. The results were analyzed using the publicly 
available script “heatmap.2” that is available for the statistical analysis program “R.” 
 
Determination of number of overlapping peptides in known bacterial proteomes 
The set of 1,632 complete bacterial proteomes was downloaded in fasta format from 
Uniprot (www.uniprot.org) using the publicly available batch retrieval perl script. Each 
of these proteomes was then parsed into all possible ten amino acid substrings and I-Ab-
binding scores for each substring were calculated. The predicted I-Ab-binding peptides 
from each bacterial proteome were taken as those with I-Ab-binding scores greater than 
the 1st percentile cutoff for mouse peptides, as determined above. Peptides of interest 
were then screened against the bacterial peptides above the 1% I-Ab-binding threshold for 
overlap at amino acid positions 2, 5, 7, and 8 using custom c++ scripts. 
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Determination of number of overlapping peptides in mouse proteome 
The Mus musculus proteome was downloaded from the NCBI website 
(ftp://ftp.ncbi.nlm.nih.gov/genomes/M_musculus/protein/protein.fa.gz). All possible ten 
amino acid substrings were extracted from these peptide sequences and each substring 
was given a score based on its homology with known I-Ab-binding peptides as published 
previously (Zhu, Rudensky et al. 2003). Using the distribution of calculated I-Ab-binding 
scores, the 1st and 5th percentile predicted I-Ab-binding score cutoff for ten amino acid 
peptides was determined. We then utilized custom c++ scripts to compare ten amino acid 
foreign peptides of interest against the top 5% I-Ab-binding mouse peptides and count the 
number of peptides with identical amino acids at positions 2, 5, 7, and 8.  
 
EAE Induction and clinical evaluation 
For determining whether the bacterial expressed peptides similar to MOG could induced 
active EAE in B6 mice (Figure 5F), mice were immunized subcutaneously with 100 µg 
of MOG39–49 or 11 amino acid versions of homologous foreign peptides emulsified in 
CFA containing 4 mg/ml Mycobacterium tuberculosis. In addition, the mice received 200 
ng of pertussis toxin (List Biological Laboratories) intravenously on the day of, and 2 
days after, peptide immunization. Individual animals were graded according to clinical 
severity as follows: grade 0, no abnormality; grade 1, limp tail; grade 2, limp tail and 
hind limb weakness; grade 3, partial hind limb paralysis; grade 4, complete hind limb 
paralysis; as previously described (Fife, Huffnagle et al. 2000). 
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Salmonella infections  
Mice were pre-treated by 12-hour food deprivation or intragastric gavage with 100 µl 5% 
sodium bicarbonate solution, pH 9.0 prior to infection. They were then given 108 S. 
enterica serovar Typhimurium (ST) strain SL1344 or recombinant S. enterica serovar 
Typhimurium strain SL1344 OmpC-2W (ST-2W, produced as described below) by 
intragastric gavage. Enrofloxacin was included in the drinking water at 2 mg/ml in some 
cases. 
 
Production of the ST-2W strain  
ST was tagged chromosomally with the 2W peptide (EAWGALANWAVDSA) as 
previously described by Uzzau et al. 2001. Briefly, primers were designed with extension 
arms homologous to the 3’ portion of the OmpC gene, deleting the stop codon, and 
extending downstream from it. Additionally, a single FLAG sequence was included, for 
blotting purposes, before reintroduction of the stop codon while kanamycin resistance 
was introduced downstream of the newly incorporated stop codon. PCR products were 
generated by amplification from a template plasmid (pJM1) encoding the 2W peptide and 
FLAG epitope. PCR products were used directly for electrotransformation into ST 
containing the temperature-sensitive pKD46 plasmid, carrying arabinose inducible 
bacteriophage λ red genes. Bacterial suspensions in 10% glycerol were mixed with 0.5–1 
µg of PCR product and incubated on ice for 30 min before transferring to a chilled 0.2-cm 
cuvette. Cuvettes were subjected to a single pulse of 12.5 kV/cm. After recovering for 1 
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hour at 37°C in SOC medium, bacteria were plated on LB agar plates supplemented with 
50 µg/ml kanamycin. DNA sequencing was used to verify recombination.  
 
Western blotting 
Wild type and ST-2W bacteria were grown overnight in LB Broth. Bacteria were 
centrifuged and pellets were suspended in 1 ml of 1X CelLytic™ B cell lysis reagent 
(Sigma), containing 0.2 mg/ml lysozyme (RPI Corp.), 50 U/ml Benzonase® Nuclease 
(Sigma), and 25 µl of Protease Inhibitor Cocktail (Sigma). Cell extracts were centrifuged 
and supernatants containing soluble proteins were removed for SDS-PAGE analysis. 
Separated proteins were transferred to a nitrocellulose membrane then blocked in 5% 
BSA for 1 hour. Membranes were probed with mouse anti-FLAG M2 monoclonal 
antibody (Sigma) at 1 µg/ml in 1% BSA for 1 hour at room temperature with gentle 
agitation. The blot was washed and then probed with 1 µg/ml of a secondary goat anti-
mouse conjugated to AlexaFluor-680 (Invitrogen) for 1 hour at room temperature. The 
blot was analyzed on an Odyssey® Imaging System (Li-Cor) at 700 nm. 
 
BrdU incorporation studies  
BrdU (Sigma-Aldrich) was dissolved in PBS at a concentration of 10 mg/ml. In vivo 
BrdU labeling was performed by intraperitoneal injection of 1 mg of BrdU on day 50 of 
ST-2W infection. 12 hours later, spleens and MLN were harvested individually and BrdU 
incorporation into DNA was detected by intracellular staining according to the 
manufacturer’s specifications (BD Biosciences). 
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Lymphokine production  
ST-2W-infected mice were injected with 100 µg of 2W peptide. Two hours later, spleens 
and mesenteric lymph node cells were harvested in media containing 10 µg/ml brefeldin 
A. The resulting cell suspensions were fixed and permeabilized and stained with IFN-γ, 
TNF, and IL-2 antibodies as previously described (Pepper, Linehan et al. 2010).  
 
Cell transfer experiments  
CD4+ T cells were isolated from spleens and lymph nodes of (CD45.1 x 129) F1 mice 
infected 50 days earlier with ST-2W and purified using Miltenyi CD4 isolation kits. The 
cells were then washed in EHAA media, suspended to a concentration of 5 x 107 cells/ml, 
incubated with 5 µM CFSE (Invitrogen) at 37oC for 10 minutes, and washed with pre-
warmed EHAA media before intravenous injection into (B6 x 129) F1 hosts. For cytokine 
experiments, purified CD4+ T cells were washed and injected intravenously without 
CFSE labeling. To control for experiment-to-experiment variability, the numbers of 
parked cells were normalized for the input number of donor-derived CD4+ T cells. 
 
Statistical analysis 
Statistical differences between normally distributed data sets were assessed in most cases 
using paired or unpaired two-tailed Student’s t tests with Prism (Graphpad) software. A 
Mann-Whitney test was used in one case where the data were not normally distributed 
(Fig. 9E). 
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Chapter 3 
 
Naïve foreign peptide-specific CD4+ T cell populations are shaped by negative 
selection on similar self peptides 
 
3.1 Introduction 
Naïve CD4+ and CD8+ T cell populations vary in size over several orders of 
magnitude (Moon, Chu et al. 2007, Kotturi, Scott et al. 2008, Obar, Khanna et al. 2008, 
Flesch, Woo et al. 2010, Schmidt, Neumann-Haefelin et al. 2011, Tan, La Gruta et al. 
2011, Kwok, Tan et al. 2012). It remains unclear, however, which factors account for this 
variability. The chemistry of peptide:major histocompatibility complex (p:MHC) 
combinations, the ligands for T cell antigen receptors (TCRs) could be one important 
determinant (Turner, Kedzierska et al. 2005, Chu, Moon et al. 2010). Peptides containing 
large hydrophobic amino acids that protrude from the MHC-binding groove appear to 
have a greater propensity to form stable TCR contacts than peptides with less featured 
amino acids. Another possibility is that foreign p:MHC-specific T cell populations with a 
high degree of cross-reactivity for self p:MHC encountered during thymic development 
may be pared by negative selection. This possibility, however, has been difficult to study 
because the rules for TCR cross-reactivity have not been worked out. 
Recent progress, however, has been made in this area for p:MHCII-specific TCRs 
expressed by CD4+ T cells (De la Herran-Arita, Kornum et al. 2013, Su, Kidd et al. 2013, 
Birnbaum, Mendoza et al. 2014). Peptides of up to 20 amino acids bind to MHCII 
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molecules via a linear nine amino acid core sequence (Rudolph, Stanfield et al. 2006). 
Certain amino acids at positions within that stretch, often at positions 1, 4, 6 and 9, 
anchor the peptide by fitting into pockets in the MHCII groove (Painter and Stern 2012). 
Because each pocket prefers one of several amino acids, certain MHCII molecules have 
the capacity to bind as many as 10% of all peptides. The amino acids at positions 2, 3, 5, 
and 8 generally point up out of the MHCII binding groove. Structural biology studies 
indicate that complementarity determining region (CDR) 1 and 2 of the TCR interact 
with the MHCII alpha helices, while CDR3 interacts mainly with the up pointing residues 
in the peptide (Marrack, Scott-Browne et al. 2008). Using soluble TCRs to probe large 
yeast-displayed MHCII-bound peptide libraries, Birnbaum, et al., found that a single 
TCR could bind dozens of peptides with similar TCR contact amino acids (Birnbaum, 
Mendoza et al. 2014) but very different MHCII anchor amino acids. If TCR specificity is 
determined by only 4 of the 9 amino acids in an MHCII-bound peptide, 1 in 160,000 
(204) peptides that bind the same MHCII molecule will have the same TCR contact 
amino acids and thus bind to the same TCR. Because a mammalian proteome can in 
theory produce 1.5x106 different MHCII-binding peptides, any given MHCII-binding 
foreign peptide should have on average about 10 MHCII-binding self peptide homologs 
(1.5x106/1.6x105). These homologs could reduce the size of the foreign peptide-specific 
population by causing negative selection. Since different foreign peptides could have 
different numbers of self-peptide homologs, the corresponding naïve cell populations 
could undergo different degrees of selection and vary in size for this reason. 
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We tested this premise in C57BL/6 (B6) mice, which express the I-Ab MHCII 
molecule. We confirmed that TCR specificity for peptides bound to I-Ab (p:I-Ab) 
depended primarily on four TCR contact amino acids and was relatively independent of 
the nature of the MHCII anchor residues. This type of TCR cross-reactivity reduced the 
size of T cell populations specific for foreign peptides with many self peptide homologs 
in the host proteome. In addition, a self peptide from a tissue restricted protein had a large 
naïve population that showed evidence of minimal evidence of negative selection and 
could be primed with bacterial peptides that shared only 4 TCR contact amino acids. 
Thus, TCR cross-reactivity between similar self and foreign peptides influenced the 
composition of the foreign peptide-specific T cell repertoire via negative selection, and 
accounted for the capacity of microbial peptides to trigger autoimmunity to an ignored 
self peptide.  
 
3.2 Results 
 
Foreign-p:I-Ab-specific naïve T cell populations vary in size.  
Earlier work indicated that naïve CD4+ T cell populations specific for 3 different 
I-Ab-bound foreign (non-mouse) peptides varied in size in B6 mice (Moon et al. 2007). 
We enumerated many more populations to get a better sense of the normal range and to 
set the stage for assessment of the effect of negative selection by related self (mouse) 
peptides. A p:MHCII tetramer-based cell enrichment and flow cytometry strategy (Moon, 
Chu et al. 2009) was used to identify naïve CD4+ T cells specific for 20 I-Ab-bound 
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foreign peptides (Table 1) in B6 mice that were never exposed to these peptides (Moon, 
Chu et al. 2007). In each case, cells from the secondary lymphoid organs were stained 
with a pair of I-Ab tetramers containing the same peptide but labeled with different 
fluorochromes, and then magnetic beads. Labeled cells were enriched on magnetized 
columns and stained with antibodies specific for informative surface markers. The 
foreign p:I-Ab-specific cells in the bound fraction were detected by gating on 
lymphocyte-sized, single cells that were stained with CD90.2 but not B220, CD11b, or 
CD11c, and with CD4 but not CD8 (Figure 1A). The double tetramer staining strategy 
was used for each of the populations to enhance the sensitivity and TCR-specificity of the 
assay (Stetson, Mohrs et al. 2002, Tubo, Pagan et al. 2013). Representative staining 
patterns for three different I-Ab-binding foreign peptides are shown in Figure 1B (left 
columns). Most double tetramer-binding cells in each population had the CD44low 
phenotype of naïve cells, indicating that the mice had no prior exposure to these epitopes. 
As quantified in Figure 1C (filled circles), the absolute number of naïve CD4+ cells 
ranged over two orders of magnitude, from fewer than an average of 5 ESAT68-16:I-Ab+ 
cells per mouse to over 500 CD4Ag28m608-616:I-Ab+ cells per mouse.  
 Mice were then immunized with 10 µg of the 20 peptides emulsified in complete 
Freund’s adjuvant (CFA) to test the hypothesis that naïve cell number predicts the 
magnitude of the effector cell response. Immunization caused clonal expansion and CD44 
induction on the relevant p:I-Ab specific T cell populations for all 20 peptides two weeks 
after immunization (Figure 1B, right columns). The hierarchy of effector cell generation 
corresponded to the number of naïve cells in most cases (Figure 1C). Across the 20 CD4+ 
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T cell populations queried, naïve cell number predicted 65% of the variance in the 
number of effector cells generated in response to peptide immunization (Figure 1D). 
These results suggest that the naïve T cell numbers shown in Figure 1C were accurate 
and solidified the conclusion that the naïve cell number predicts the magnitude of the 
effector cell response. 
 
Determining the nonamer core peptides for p:I-Ab  
It was next necessary to identify the TCR contact amino acids for the 20 foreign 
peptides to make it possible to search for mouse peptides with matching residues. The 
strategy was to identify the amino acids in the foreign peptides that bound to I-Ab, which 
by default would identify the other amino acids as up pointing TCR contacts. Zhu et al. 
(Zhu, Rudensky et al. 2003) had already identified an I-Ab binding motif for nonamer 
peptides by aligning the sequences of 78 peptides eluted from I-Ab. We used this motif to 
align an additional 128 I-Ab-bound peptides (Dongre, Kovats et al. 2001, Karunakaran, 
Rey-Ladino et al. 2008) (Table 2A) with the goal making the motif more accurate. We 
assumed that a correct alignment would reveal certain preferred amino acids at positions 
in the peptide that occupied I-Ab binding pockets. Indeed, the aligned peptides contained 
tyrosine, tryptophan, for phenylalanine at position (P) 1, proline at P4, proline or alanine 
at P6, and asparagine at P7 at frequencies that were at least 3 times greater than predicted 
by the average overall abundance of these amino acids in organisms. This result is 
consistent with the interpretation that the side chains of the P1, 4, 6, and 7 amino acids 
occupy pockets in I-Ab as proposed by other investigators (Liu, Dai et al. 2002, Zhu, 
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Rudensky et al. 2003). In contrast, P2, 3, 5, 8, and 9 of the aligned peptides did not show 
greater than 3-fold enrichment for any amino acid suggesting that these residues do not 
play major roles in I-Ab binding, although structural biology studies indicate that P9 plays 
a minor role (Zhu, Rudensky et al. 2003). These results suggest that peptides bind to I-Ab 
mainly by certain amino acids at P1, 4, 6, and 7.  
 The data in Table 2B was then used to identify the most likely I-Ab-binding 
register for each of the 20 foreign peptides in the I-Ab tetramers used in Figure 1. For 
peptides that were longer than 9 amino acids, the possible nonamers were given a score 
based on the sum of the frequency values for the 9 amino acids as determined from Table 
2B. In each case, one of the possible nonamers had a much higher score than the others 
and was chosen as the I-Ab-binding core for that peptide (Table 1).   
If the I-Ab binding registers shown in Table 1 are correct, then P5 should be the 
most important amino acid for TCR recognition because the CDR3 alpha and beta 
regions of TCRs generally interact with this amino acid (Marrack, Scott-Browne et al. 
2008). An alanine substitution scan was performed to test this possibility. All alanine 
substituted peptides were predicted to bind I-Ab binding because alanine occurred often at 
P1, 6, 4, and 7 in the set of 206 I-Ab-bound peptides shown in Table 2. Because it was not 
clear whether amino acids flanking the I-Ab-bound nonamers could serve as additional 
TCR contacts, mice were primed with 11 amino acid versions of 13 of the 20 foreign 
peptides. Two weeks later, CD4+ T cells from the draining lymph nodes were stimulated 
with the priming peptide, or peptides with single alanine substitutions within the nonamer 
core plus as well as the P-1 and P10 N- and C-terminal flanking residues. The T cell 
  24 
response was then measured by the interferon-γ Enzyme-Linked ImmunoSpot 
(ELISPOT) assay. Alanine substitutions at the predicted P5 residues reduced reactivity by 
parent peptide-primed T cells by an average of 90% (Figure 2A). Substitutions at P2, 3, 
or 8 also reduced T cell reactivity by at least 60% as predicted for TCR contact residues 
(Huseby, White et al. 2005). In contrast, substitutions at P1 or 9, as well as the flanking 
amino acids, reduced T cell reactivity on average less than 30%. These results are 
consistent with P2, 3, 5, and 8, but not P1, P9, or flanking amino acids being TCR contact 
residues for I-Ab-bound peptides.  
It was surprising, however, to find that substitutions at P4, P6, and P7 reduced cell 
reactivity by parent peptide-primed T cells because Table 2B and structural biology 
experiments (Liu, Dai et al. 2002, Zhu, Rudensky et al. 2003) indicate that these positions 
are I-Ab anchors. Because there was some variability in the effect of alanine substitution 
across the 13 peptides as evidenced by the large standard deviations in Figure 2A, an 
unsupervised clustering of amino acid positions was performed as an independent way to 
identify the important TCR contact amino acids (Figure 2B). As expected, P2, 5, and 8 
clustered for large effects on TCR recognition. Notably, P7 clustered with these amino 
acids better than P3. P1, 4, 6, and 9 clustered for smaller effects on TCR recognition. 
These results and those in Table 2B suggest that peptides are anchored to I-Ab by 
primarily by amino acids at P1, 4, 6, and 7, with a small contribution from P9 and that 
amino acids at P2, 5, 7, and 8 are the main TCR contacts with a smaller contribution from 
P3. The behavior of P7 as an I-Ab anchor and TCR contact is consistent with the fact that 
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it occupies a shallow pocket in I-Ab allowing amino acid side chains to protrude for 
recognition by TCRs (Zhu, Rudensky et al. 2003).   
 
TCR contact amino acid conservation predicts p:MHCII cross-reactivity within 
polyclonal CD4+ T cell populations 
The knowledge that amino acids at P2, 3, 5, 7, and 8 are the TCR contacts for I-
Ab-bound peptides made it possible to test the limits of cross-reactivity for I-Ab-restricted 
TCRs. Over a 1,000 bacterial proteomes were searched for predicted I-Ab-binding 
nonamer peptides that matched the 3K, LLO, GP66, and 2W peptides at 4 of the P2, 3, 5, 
7, or 8 amino acids but at most one of the P1, 4, or 9 amino acids. Three such peptides 
were identified for 3K, 1 for LLO, and 5 for GP66 and 2W. B6 mice were then primed 
with the parent 3K, LLO, GP66, or 2W peptides, or the corresponding variant peptides 
and the number of responding CD4+ T cells was measured with 3K, LLO, GP66, or 
2W:I-Ab tetramers. If TCR cross-reactivity existed between a parent peptide and a variant 
peptide, then priming with the variant peptide should induce the clonal expansion of at 
least a subset of the T cells specific for the parent p:I-Ab ligand. As expected, mice 
primed 11 days earlier with 3K, LLO, GP66, or 2W peptides in CFA had large 
populations of CD44high cells that bound to the parent p:I-Ab tetramer (Figure 3A). 
Priming with the parent peptide caused this clonal expansion as evidenced by the fact that 
mice primed with CFA alone had about the same number of parent p:I-Ab-specific cells 
as naïve mice. The cells in mice primed with CFA alone were also phenotypically naïve 
based on low expression of CD44, with the exception of the 2W:I-Ab-specific population, 
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which had a small population of CD44high cells. Remarkably, 1 of 3 3K, 1 of 1 LLO, 2 of 
5 GP66, and 4 of 5 2W variant peptides primed significant expansion of CD44high CD4+ 
T cells capable of binding the relevant parent p:I-Ab tetramer (Figure 3B). Three of the 
2W variant peptides stimulated the expansion of 2W:I-Ab-specific cells despite sharing 
no I-Ab anchor residues with the 2W peptide. Thus, 8 of 14 (57%) of I-Ab-binding 
peptides sharing 4 TCR contact amino acids but at most one I-Ab anchor residue 
exhibited significant TCR cross-reactivity.  
 
Self-p:MHCII cross-reactivity limits naïve population size and responsiveness to 
homologous foreign-p:MHCII 
The findings in Figure 3 raised the possibility that TCR cross-reactivity between 
mouse and non-mouse peptides could reduce the size of non-mouse peptide-specific 
naïve populations in mice due to negative selection. A proof of principle experiment was 
performed with the 2W peptide, a variant called to 2W109 with the same amino acids at 
P2, 3, 5, 7, and 8 as the 2W peptide but different residues at P1, 4, 6, and 9 (Figure 4A), 
and a transgenic mouse expressing the 2W peptide as a self antigen. The 2W epitope is a 
foreign peptide in B6 mice, and is recognized by a diverse population of approximately 
300 naïve CD4+ T cells (Figure 1A) (Moon, Chu et al. 2007). We have previously shown 
that expression of 2W peptide as a self-peptide under the control of the actin promoter in 
Act-2W transgenic mice induces tolerance and leads to deletion of 2W:I-Ab-reactive cells 
(Moon, Dash et al. 2011).  
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 Naïve 2W109:I-Ab-specific T cells were enumerated with 2W109:I-Ab tetramer in 
B6 and Act-2W mice to assess whether TCR cross-reactivity could cause negative 
selection. As shown in Figure 4B, B6 mice contained a large population of approximately 
1,000 2W109:I-Ab-specific naïve CD4+ T cells in the spleen and lymph nodes. In 
contrast, Act-2W mice had only 400 2W109:I-Ab-specific naïve cells. The reduction was 
likely due to deletion of 2W:I-Ab/2W109:I-Ab cross-reactive clones, as there was no 
difference in the number of LLO:I-Ab-specific naïve cells in the two strains.  
 An ELISPOT approach was also used to study the fine specificity of the 2W109:I-
Ab-specific cells that were not deleted in mice expressing 2W:I-Ab. The hypothesis was 
that the population of 2W109:I-Ab-specific cells in B6 mice contains two subpopulations; 
one with TCRs that bind the TCR contact amino acids in a geometry that is not affected 
by the I-Ab anchor residues, and one with TCRs that bind the TCR contact amino acids in 
a geometry that is. The cross-reactive subpopulation would be deleted in Act-2W mice, 
while the non-cross-reactive one would remain. The prediction would be that the 
remaining non-cross-reactive 2W109:I-Ab-specific population would be sensitive to 
substitutions at I-Ab anchor positions since it is focused on an I-Ab anchor position-
dependent conformation of the TCR contacts. In B6 mice, the reactivity of 2W109:I-Ab-
specific CD4+ T cells was reduced by at least 50% when stimulated with peptides 
containing substitutions at P2, 5, or 8 (Figure 4C, black bars). In contrast, in Act-2W 
mice, the reactivity of the 2W109:I-Ab-specific population was reduced by at least 50% 
when stimulated with peptides containing substitutions at P2, 3, 4, 5, 6, 7, or 8 (Figure 
4C, white bars). Thus, the 2W109:I-Ab-specific population that survived negative 
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selection in the presence of 2W:I-Ab appeared to be specific for TCR contact amino acids 
in an I-Ab anchor residue-dependent fashion. 
These results demonstrate that a foreign peptide-specific population can be 
reduced in size because of deletion of cells that cross-react on a self peptide with the 
same TCR contacts but different MHCII anchors. Furthermore, the surviving cell 
population had a signature of exposure to the self peptide of remarkable dependence on 
the character of the MHCII anchor residues. These results raised the possibility that small 
foreign peptide-specific populations are small because of deletion of cells with TCRs that 
are cross-reactive on self peptides with the same TCR contacts but different MHCII 
anchors. If so, then the expectation would be that the specificity of these populations 
would be more dependent on the character of the MHCII anchor residues than large 
populations. Indeed, a significant inverse correlation was observed between the number 
of naïve cells in a foreign peptide-specific population and the average effect of 
substitutions at I-Ab anchors P1, 4, 6, and 7 on the reactivity of T cells in that population 
(Figure 4D).  
To further test the hypothesis that naïve populations specific for foreign peptides 
are shaped by negative selection on self-peptides with similar TCR contact amino acids, 
we searched for self-peptides that could have contributed to negative selection for each of 
the foreign p:I-Ab-specific CD4+ T cell populations. A bioinformatic screen was 
developed to identify mouse peptides that were predicted to bind I-Ab and share TCR 
contact amino acids with the non-mouse peptides of interest. To be inclusive for any self 
p:I-Ab that could have an effect, the stringency of the search was reduced to include any 
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combination of 4/5 identical amino acid residues at P2, 3, 5, 7, and 8. Mouse peptide 
homologs were identified for all the foreign peptides, with a range of 3 to 181. The 
complete list of mouse peptide homologs along with the associated gene names can be 
found in Supplemental Figure 1. Importantly, a significant inverse correlation was 
observed between naïve CD4+ T cell population size and the number of self peptide 
homologs (Figure 4E), although the r2 value was only 0.27. These results support the 
conclusion that TCR cross-reactivity on self peptides plays some role in determining the 
size of MHCII-bound foreign peptide specific CD4+ T cell populations. 
 
A tissue restricted self p:MHCII is recognized by a large naïve T cell population 
with minimal evidence of negative selection 
The results indicated that negative selection on a self peptide with the same TCR 
contact amino acids could reduce the size of a foreign peptide-specific CD4+ T cell 
population. We considered the corollary case in which a self peptide-specific CD4+ T cell 
population that had not undergone complete deletion could be triggered to cause 
autoimmunity by a foreign peptide with the same TCR contact amino acids. The self 
(mouse) peptide of interest was peptide 31-50 from myelin oligodendrocyte glycoprotein 
(MOG), a brain protein which causes experimental acute encephalomyelitis (EAE) in B6 
mice when injected with CFA and pertussis toxin (Miller, Karpus et al. 2010). Limited 
presentation of I-Ab-bound MOG peptide in the thymus probably explains why not all I-
Ab-bound MOG peptide-specific T cells are deleted (Ben-Nun, Kerlero de Rosbo et al. 
2006). We produced an I-Ab tetramer containing MOG40-48 to study relevant CD4+ T 
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cells. As shown in Figure 5A, B6 mice that were not immunized with MOG40-48 
contained about 250 CD44low naïve CD4+ T cells (Fig. 5A and B), which was at the high 
end of the range for I-Ab-bound foreign peptides (Figure 1B). Recall of MOG40-48-primed 
T cells with MOG40-48 peptides containing single alanine substitutions showed that the T 
cells depended primarily on P1, 2, 5, 7, and 8 (Figure 5C). Alanine substitution at I-Ab 
anchors at P1, 4, 6, or 7 resulted in an average reduction in T cell reactivity of 60%, 
which was consistent with a moderate degree of negative selection based on the results in 
Figure 4E. In addition, the mouse proteome only contains 19 predicted I-Ab-binding 
peptides that share 4 of 5 amino acids with MOG40-48 at P2, 3, 5, 7, or 8, suggesting that 
negative selection by homologous self peptides was probably minimal. Injection of 
MOG40-48 in CFA plus pertussis toxin resulted in the expansion of MOG40-48:I-Ab 
tetramer-binding T cells, providing further evidence that not all cells in this repertoire 
were negatively selected. We then search bacterial proteomes for peptides that were 
predicted to bind I-Ab and matched MOG40-48 at P1, 2, 5, 7, and 8 but differed at P3, 4, 6, 
and 9. Three such peptides were identified and used to immunize B6 mice. As shown in 
Figure 5D and E, all three peptides induced expansion of CD44high MOG40-48:I-Ab 
tetramer-binding T cells to varying degrees, although not as well as MOG40-48 itself. Two 
of the three bacterial peptides, the two that stimulated the most expansion of MOG40-48:I-
Ab-specific T cells, also caused EAE, although again not as well as MOG40-48 (Figure 
5F). These results demonstrate that a tissue-restricted self peptide that is capable of 
inducing autoimmunity after priming is recognized by a large naïve population that can 
also be activated by bacterial peptide homologs with the same TCR contact amino acids.  
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3.3 Discussion 
 
This study adds to recent advances in the understanding of TCR cross-reactivity. 
Work from several laboratories on multiple MHCII allelomorphs has come to the 
conclusion that many MHCII-restricted TCRs can recognize certain peptides sharing 
most of the amino acids that protrude from the binding groove but differing dramatically 
at the amino acids that anchor the peptide to MHCII. Our results confirm this conclusion 
for the I-Ab MHCII molecule by showing that I-Ab-binding peptides sharing 4 of 5 
putative TCR contact amino acids but no MHCII anchor amino acids with the parent 
peptide were immunogenic for T cells specific for parent peptide. In addition, we found 
that this type of TCR cross-reactivity extends to negative selection as evidenced by the 
60% reduction in the 2W109:I-Ab-specific naïve cell population in mice expressing the 
2W peptide that shares only TCR contact amino acids with 2W109 peptide. These results 
suggest that many MHCII-restricted TCRs focus primarily on the TCR contact amino 
acids no matter how the peptide is anchored to MHCII. This conclusion is supported by 
structural biology studies showing that peptides that bind MHCII with different amino 
acids but have the same up pointing amino acids orient those amino acids in very similar 
(but non-identical) ways, and are bound with the same footprint by cross-reactive TCRs.  
Many TCRs could, however, distinguish between the subtle orientations of TCR 
contact amino acids in peptides that share these residues but have different MHCII 
anchors. This conclusion is supported by the finding that some I-Ab-binding variants 
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sharing 4 of 5 putative TCR contact amino acids with the parent foreign peptide but with 
different I-Ab anchor amino acids were not immunogenic for T cells specific for the 
parent ligand. It is possible that the I-Ab anchor amino acids in these variant peptides alter 
the conformation of the TCR contact amino acids to the point of being unrecognizable to 
TCRs focused on the conformation of the parent peptide. The observation that the 
2W109:I-Ab-specific T cells that could not recognize the related 2W:I-Ab ligand were 
unusually sensitive to substitutions at MHCII anchor positions in the 2W109 peptide is 
consistent with this possibility. It is unlikely that these TCRs directly recognized the I-Ab 
anchor amino acids themselves because structural studies indicate that the side chains of 
these residues are completely buried in the I-Ab molecule. Rather, these MHCII anchor 
amino acids probably created alterations in the geometry of nearby TCR contact amino 
acids, which can be detected by certain TCRs. 
Like the 2W109:I-Ab-specific cells that survived deletion in mice expressing 2W 
peptide, the T cells in small naïve populations were sensitive to substitutions at both TCR 
contact and MHCII anchor positions in the cognate foreign peptide, while T cells in large 
naïve populations were usually sensitive only to substitutions in TCR contact residues. 
These results are consistent with the possibility that the small naïve populations are small 
because they experienced more negative selection than the large populations, and support 
earlier work by Huseby et al. showing that T cells that develop under conditions of 
minimal negative selection have highly cross-reactive TCRs (Huseby, White et al. 2005).  
Self peptides were the likely causes of negative selection that produced small 
naïve populations. This contention is based on an inverse correlation between the number 
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of cells in a given foreign (non-mouse) peptide-specific naïve cell population and the 
number of predicted I-Ab-binding mouse peptides with the same TCR contacts as the 
foreign peptide. Although none of the 21 I-Ab-binding foreign peptides had an identical 
nonamer in the mouse proteome, all 21 peptides had at least 3 and as many as 181 
predicted I-Ab-binding mouse peptides with 4 of 5 of the same TCR contacts as the 
foreign peptide. Our finding with the 2W109/2W pair showed that this degree of 
similarity could cause deletion of 60% of the cells in a foreign peptide-specific repertoire 
in a case where the self peptide was abundantly expressed in the thymus. The following 
hypothetical scenario illustrates how the process may work.  Consider a case of 2 mouse 
nonamer peptides (S1 and S2) that have the same amino acids at P2, 5, 7, and 8 but 
different amino acids at P1, 4, and 6. Both peptides are displayed on I-Ab molecules in 
the thymuses of B6 mice. A third non-mouse peptide (F1) has the same amino acids at 
P2, 5, 7, and 8 as the two mouse peptides but different I-Ab-binding amino acids at P1, 4, 
and 6. The TCR contact amino acids in the 3 complexes adopt slightly different 
conformations, s1, s2, and f1, respectively, due to subtle effects of the different I-Ab 
anchor amino acids. B6 mice produce thymocyte populations with TCRs that bind s1 
only, s2 only, f1 only, s1 and s2, s1 and f1, s2 and f1, and s1 and s2 and f1. Negative 
selection will delete all the populations with TCRs specific for s1 and/or s2, leaving a 
subpopulation with TCRs that bind f1 only. Since the TCRs in this population are highly 
specific for the f1 conformation, substitutions in any of the I-Ab anchor amino acids in 
the F1 peptide are likely to cause loss of TCR binding. In a different mouse strain that 
expresses I-Ab but lacks the S1 and S2 peptides, the F1-specific population would be 
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much larger, and contain cells that are not so fussy about which I-Ab anchor amino acids 
neighbor the TCR contact amino acids. An implication of this model is that large naïve 
populations are not only more helpful to the host during infection by generating large 
numbers of effector cells, but also because these cells express TCRs that are more 
tolerant to antigen variants produced by the pathogen.  
This model may also be relevant for certain forms for autoimmunity caused by 
peptides from proteins with tissue-restricted patterns of expression. We found that one 
such peptide, MOG40-48 derived from the brain protein MOG, was recognized by a 
surprisingly large naïve T cell population as if had not been subjected to negative 
selection. This conclusion was supported by the finding that MOG40-48:I-Ab-specific T 
cells were not sensitive to alanine substitutions at P4 or P6 of the peptide, like foreign 
p:I-Ab-specific T cell populations with few homologous self peptides. The MOG40-48:I-
Ab-specific T cell repertoire may experience minimal negative selection because relevant 
p: I-Ab ligands are not displayed in the thymus (Ben-Nun, Kerlero de Rosbo et al. 2006). 
MOG is expressed primarily in the brain so thymic antigen-presenting cells may not 
display MOG40-48:I-Ab complexes. In addition, we found very few predicted I-Ab-binding 
peptides in the mouse proteome with the same TCR contact amino acids as MOG40-48 that 
could cause negative selection of MOG40-48:I-Ab-specific T cells. The large size of this 
population may also make it susceptible to activation by I-Ab-binding microbial peptides 
with the same TCR contact amino acids. Activation of even of a subset of the large 
MOG40-48:I-Ab-specific T cell by one of these mimics during infection might be enough 
to cause autoimmunity as in our test case shown in Figure 5F. A similar situation was 
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recently described for humans by De la Herran-Arita et al. CD4+ T cells with TCRs 
specific for a peptide from a nervous system protein called hypocretin bound to the HLA-
DQ0602 MHCII molecule also recognized an influenza hemagglutinin peptide:HLA-
DQ0602 complex (De la Herran-Arita, Kornum et al. 2013). The peptides shared similar 
TCR contact amino acids at P2, 5, 7, and 8 and also had relatively conserved substitutions 
at P1, 4, 6, and 9 MHCII anchor amino acids. Thus, it is conceivable that influenza 
infection or vaccination caused the expansion of these dual-reactive T cells that entered 
the nervous system and caused narcolepsy.  
Finally, our results suggest that large and potentially immunodominant foreign 
peptides can be predicted based on a paucity of tolerance-inducing self peptide homologs. 
The predictive capacity of this approach is far from perfect, however, as evidenced by a 
relatively weak correlation between the number of predicted mouse peptide homologs 
and foreign peptide-specific naïve T cell population size. One problem is that peptides 
that share TCR contact amino acids but have different MHCII anchor amino acids are 
often, but not always, recognized by the same TCRs. This uncertainty means that some of 
the mouse peptide homologs that were predicted to cause negative selection probably do 
not. Another reason that many of the predicted MHCII-binding mouse peptides may not 
cause tolerance is that the parent protein is not expressed by thymic antigen-presenting 
cells or is not processed correctly to release the peptide. Thus, better prediction of the 
size of naïve T cell populations specific for foreign peptides will likely depend on a better 
understanding TCR specificity and the self peptides that cause negative selection. If these 
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hurdles can be cleared, it may be possible to identify the most immunogenic peptides 
from pathogens and use that information to design effective subunit vaccines.  
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Peptide  Position (P)  PSSM1 PSSM2
         123456789
      ** * **
ESAT68-16    QQWNFAGIEAAASA  17.95 17.90
FliC431-439    VQNRFNSAITNLGNT  20.34 10.94
STM154049-57     VYYTTYAPQAT  26.35 25.26
STM154051-59     YTTYAPQATSA  23.39 26.35
eGFP85-93     HDFFKSAMPEGYVQE  16.61 15.03 
OVA3C329-337      GHAAHAEINEA  16.64 16.94 
RpIF51-59        FVSPAAHII  29.40 10.03 
OVA2C326-334       QAVHAAHAEIN  10.09 18.32
3K        EAQKAKANKAVDKA 18.13  8.74  
Calnex105-113 LVVKNPAAHHAIS  24.44 10.65  
Aasf24-32    VSSPAVQES  22.15  8.15 
1G1W     EAGGALANWAVDSA 18.71 12.69 
LLO193-201     NEKYAQAYPNVS  32.14 15.84 
Derp1113-121      CQIYPPNVNKI  22.75 13.08 
MP98220-228  HQYMTALSNEVVF  29.34 11.81 
PmpG-1303-311   YVDPAAAGG  36.13 13.93
CTB28-36   NNKTPHAIAAIS  21.57 13.61
GP6668-76    DIYKGVYQFKSV  21.16 20.22
2W      EAWGALANWAVDSA 19.59 12.69 
CD4Ag28m608-616 VEIHRPVPGTA  23.68 14.33
     ^  ^ ^^ ^
Table 1
 
 
Table 1. Nonamer cores of 20 foreign I-Ab-binding peptides  
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A
B
Position A C D E F G H I K L M N P Q R S T V W Y
P1 9 1 2 1 41 1 5 5 1 8 3 3 1 2 0 1 3 19 12 88
P2 13 0 16 15 5 8 11 7 7 10 3 13 6 12 13 20 20 20 3 4
P3 38 1 11 11 6 29 1 2 2 6 3 12 13 8 1 33 15 8 4 2
P4 28 0 1 0 1 7 1 2 3 3 0 1 125 1 1 24 5 3 0 0
P5 23 1 6 12 4 10 9 8 13 9 3 9 2 16 7 23 20 25 3 3
P6 55 0 2 1 2 13 0 22 1 3 1 3 54 2 0 10 11 26 0 0
P7 26 0 2 11 0 18 13 5 1 23 1 41 1 11 2 25 12 9 3 2
P8 11 0 6 17 5 12 2 18 9 17 1 4 26 11 10 17 14 16 1 9
P9 35 1 11 11 3 11 5 9 0 14 2 10 4 4 6 34 9 34 0 3
Position A C D E F G H I K L M N P Q R S T V W Y
P1 0.6 0.2 0.2 0.1 5.1 0.1 1.0 0.6 0.1 0.4 0.6 0.4 0.1 0.2 0.0 0.1 0.3 1.5 6.0 14.7
P2 0.9 0.0 1.6 1.1 0.6 0.6 2.2 0.8 0.6 0.5 0.6 1.9 0.5 1.2 1.1 1.2 1.8 1.5 1.5 0.7
P3 2.7 0.2 1.1 0.8 0.8 2.2 0.2 0.2 0.2 0.3 0.6 1.7 1.0 0.8 0.1 1.9 1.4 0.6 2.0 0.3
P4 2.0 0.0 0.1 0.0 0.1 0.5 0.2 0.2 0.3 0.1 0.0 0.1 9.6 0.1 0.1 1.4 0.5 0.2 0.0 0.0
P5 1.6 0.2 0.6 0.9 0.5 0.8 1.8 0.9 1.1 0.4 0.6 1.3 0.2 1.6 0.6 1.4 1.8 1.9 1.5 0.5
P6 3.9 0.0 0.2 0.1 0.3 1.0 0.0 2.4 0.1 0.1 0.2 0.4 4.2 0.2 0.0 0.6 1.0 2.0 0.0 0.0
P7 1.9 0.0 0.2 0.8 0.0 1.4 2.6 0.6 0.1 1.1 0.2 5.9 0.1 1.1 0.2 1.5 1.1 0.7 1.5 0.3
P8 0.8 0.0 0.6 1.2 0.6 0.9 0.4 2.0 0.8 0.8 0.2 0.6 2.0 1.1 0.8 1.0 1.3 1.2 0.5 1.5
P9 2.5 0.2 1.1 0.8 0.4 0.8 1.0 1.0 0.0 0.7 0.4 1.4 0.3 0.4 0.5 2.0 0.8 2.6 0.0 0.5
Predicted # 14 5 10 14 8 13 5 9 12 21 5 7 13 10 12 17 11 13 2 6
Table 2
 
 
Table 2. MHCII anchoring characteristics for p:I-Ab 
(A) I-Ab binding matrix produced by aligning sequences of peptides eluted from I-Ab in 
mass spectrometry studies. 
(B) Frequency of amino acids at indicated positions, relative to expected occurrence 
based upon random distribution of amino acids in mouse proteome (shown in Table 1A, 
bottom row).  
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Figure 1. Relationship between p:I-Ab-specific CD4+ T cell population sizes in 
unimmunized and immunized mice 
(A) Gating strategy for detecting p:I-Ab tetramer bound populations in secondary 
lymphoid tissues.  
(B) Plots of double tetramer staining (far left) and CD44 expression (left) for CD4+ T 
cells from spleen and LN of individual naive B6 mice following enrichment with the 
indicated p:I-Ab tetramers labeled with two different fluorochromes. The plots on the 
right represent staining of the same populations in spleen and draining lymph nodes 14 
days after priming subcutaneously with 10 µg of the indicated peptide emulsified in CFA. 
(C) Total number of tetramer-binding CD4+ T cells for the 20 unique foreign-p:I-Ab 
ligands in individual unimmunized (open circles) and immunized (closed circles) mice as 
identified in (B) (horizontal bars indicate mean values). 
(D) Linear correlation between the average Log10 (naive cell number) and Log10 
(effector cell number) for each of the populations identified in (C). 
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Figure 2. Alanine substitution analysis of CD4+ T cell responses to known foreign 
epitopes 
(A) P-1 to P10 alanine substituted variant peptides were tested as stimulators of a 
secondary in vitro response of peptide-primed CD4+ T cells from draining inguinal and 
para-aortic lymph nodes, as described in Materials and Methods. The average response at 
each position across 13 scanned peptides was determined as “% TCR response” as 
compared to the priming peptide control (100%) (+/- SD, n = 3 mice, individual wells in 
triplicate).  
(B) Unsupervised clustering of P-1 to P10 for “% TCR response” after stimulation with 
alanine substituted peptides for each of the 13 indicated priming peptides.   
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Figure 3. Conservation of TCR contact amino acids predicts p:I-Ab cross-reactivity 
(A) Representative plots showing staining with the indicated parent p:I-Ab tetramer of 
spleen and lymph node cells from mice primed with CFA alone (no peptide, negative 
control), bacterial-encoded homologous peptide (variant peptide), or parental peptide 
(positive control), 11 days after injection of subcutaneous injection.  
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(B) Average number of 3K:I-Ab+, LLO:I-Ab+, GP66:I-Ab+, and 2W:I-Ab+ CD4+ T cells 
after priming with the indicated peptides emulsified in CFA (+/- SEM, n = 3). 
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Figure 4. Cross-reactivity with self-p:MHCII affects foreign-p:MHCII cell number 
(A) Sequence alignment of 2W and 2W109 nonamer peptides. Putative TCR contact 
residues shared between the peptides are in bold. 
(B) Number of 2W109:I-Ab+ and LLO:I-Ab+ CD4+ T cells in unimmunized B6 and Act-
2W mice (***p < 0.0001, n.s. = not significant). 
(C) P1 to P9 alanine substituted 2W109 variant peptides were tested as stimulators of a 
secondary in vitro response of 2W109 peptide-primed CD4+ T cells from draining 
inguinal and para-aortic lymph nodes of B6 (black bars) or Act-2W (white bars) mice. 
The average % response, relative to 2W109 peptide stimulation (100%) is shown (+/- SD, 
n = 3 mice, individual wells in triplicate). 
(D) Linear correlation between the average effect from each Ala-substituted variant (% 
reduction relative to priming peptide control) at the critical I-Ab anchor residues at P1, 
P4, P6, and P7 versus the Log10 (average naïve cell number). 
(E) Linear correlation between the number of mouse self peptides predicted to bind I-Ab 
and match each of the foreign peptides in Table 1 at at least 4 TCR contact positions (P2, 
P3, P5, P7, P8) versus the Log10 (average naïve cell number). 
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Figure 5. TCR cross-reactivity with foreign peptides similar to MOG:I-Ab can elicit 
EAE.  
(A) Plots of double tetramer staining (top) and CD44 expression (bottom) for MOG:I-Ab-
specific CD4+ T cells from spleen and LN of individual unimmunized B6 mice following 
enrichment with MOG:I-Ab tetramer labeled cells.  
(B) Total number of MOG:I-Ab tetramer-binding CD4+ T cells in individual 
unimmunized mice (horizontal bars indicate mean values). 
(C) P1 to P9 alanine substituted MOG variant peptides were tested as stimulators of a 
secondary in vitro response of MOG peptide-primed CD4+ T cells from draining inguinal 
and para-aortic lymph nodes of B6 mice. The average % response, relative to MOG 
peptide stimulation (100%) is shown (+/- SD, n = 3 mice, individual wells in triplicate). 
(D) Representative plots indicating clonal expansion and CD44 expression of MOG:I-Ab-
specific cells 14 days after priming subcutaneously with 10 µg of the indicated 
homologous foreign peptide emulsified in CFA. 
(E) Average number of MOG:I-Ab+ CD4+ T cells after priming with 10 µg of the 
indicated peptides (+/- SEM, n = 3). 
(F) EAE disease course after subcutaneous immunization with the 100 µg of the indicated 
peptides in (E) plus intravenous injection of 200 ng pertussis toxin on day 0 and day 2, as 
described in Materials and Methods. 
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Chapter 4 
 
CD4+ T cell persistence and function after infection is maintained by low-level 
peptide:MHCII presentation 
 
4.1 Introduction 
Expanded populations of antigen-specific T and B cells that persist long after 
pathogen clearance are responsible for immunological memory. These cells are useful to 
the host, providing protective immunity to subsequent challenge by the original microbe. 
The memory cell paradigm has been established most clearly for CD8+ T cells (Lau, 
Jamieson et al. 1994). CD8+ T cells expressing TCRs specific for microbe peptide:MHCI 
ligands proliferate extensively, producing a peak number of effector cells about a week 
after acute infection. About 90% of these effector cells then die by apoptosis, leaving a 
population of memory cells that is stably maintained by recurrent IL-15-driven 
homeostatic proliferation. Central memory CD8+ T cells (Tcm) re-circulate through 
secondary lymphoid organs, producing new memory cells during secondary responses, 
while effector memory (Tem) cells located in non-lymphoid organs are immediately 
cytotoxic during secondary responses.  
It is less clear whether the concept of stable immune memory applies to CD4+ T 
cells. Naïve CD4+ T cells expressing TCRs specific for microbe peptide:MHCII ligands 
proliferate extensively to produce a peak number of effector cells about a week after 
acute infections with Lymphocytic Choriomeningitis Virus (LCMV) or Listeria 
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monocytogenes (Homann, Teyton et al. 2001, Pepper, Linehan et al. 2010). As in the case 
of CD8+ T cells, about 90% the effector cells then die, leaving a population of memory-
phenotype cells, about half of which are Th1 cells and the other half follicular helper cell-
like Tcm cells (Pepper, Pagán et al. 2011). Although both CD4+ and CD8+ T cells are 
maintained by recurrent IL-15-driven homeostatic proliferation, the proliferation rate is 
much lower for CD4+ memory T cells than for CD8+ memory T cells (Sprent 2008, 
Pepper, Linehan et al. 2010). Thus, CD4+ memory T cells slowly decline in number after 
infection is cleared, probably because their lower rate of homeostatic proliferation cannot 
keep pace with their death rate. 
Previous studies showing the decline of CD4+ memory T cells involved acute 
infections, which were completely cleared by CD8+ T cells and innate immune cells with 
no apparent involvement of CD4+ T cells (Matloubian, Concepcion et al. 1994, Portnoy, 
Auerbuch et al. 2002). Infections that are controlled by CD4+ T cells (Reith and Mach 
2001) are caused by microbes such as Mycobacterium, Leishmania, and Salmonella 
species, that establish persistent infections in the phagosomes of phagocytes. In these 
cases, CD4+ T cells contain, but never fully clear the microbes from the initial site of 
infection, while providing sterilizing immunity at all other body sites (Belkaid, Hoffmann 
et al. 2001, Monack, Mueller et al. 2004, Urdahl, Shafiani et al. 2011). Notably, clearance 
of the original infection is associated with loss of systemic immunity (Belkaid, Piccirillo 
et al. 2002), indicating that the maintenance of protective CD4+ T cells depends on 
persistent antigen, as suggested by several recent studies (Lin, Kemball et al. 2010, 
Reiley, Shafiani et al. 2010, Stephens and Langhorne 2010). The requirement for 
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persistent antigen presentation for CD4+ T cell maintenance goes against the idea derived 
from studies of CD8+ T cells that durable memory and immune protection develop after 
antigen is cleared while exhaustion ensues if it is not cleared.  
Here, we assessed CD4+ T cell responses to the facultative intracellular bacterium 
Salmonella enterica that can infect mice and humans through the gastrointestinal tract. 
Mice expressing Nramp1, a protein that helps limit bacterial replication in phagocytes, 
develop a persistent infection following oral inoculation, which is controlled by IFN-γ-
producing CD4+ T cells (de Jong, Altare et al. 1998, Monack, Bouley et al. 2004). In the 
current study, we developed a model to study a p:MHCII-specific immune response to 
Salmonella enterica serovar Typhimurium (ST) infection in Nramp1-resistant 
(Nramp1Gly169/Gly169, referred to hereafter as Nramp1R) mice to understand how bacterial 
persistence and p:MHCII presentation affect the numerical and functional stability of 
protective CD4+ T cells.  
 
4.2 Results 
Generation of Salmonella expressing an immunodominant CD4+ T cell epitope 
Before monitoring the stability of CD4+ T cells during persistent ST infection, it 
was necessary to identity a relevant epitope. Although epitopes consisting of I-Ab 
molecules complexed with peptides from the FliC and SseJ proteins of ST have been 
described (Lee, McLachlan et al. 2012), the CD4+ T cell populations that recognize them 
are very small (Moon, Chu et al. 2007). One of the largest naïve CD4+ T cell populations 
identified to date is specific for a peptide called 2W (Moon, Chu et al. 2007), which is a 
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variant of MHCII I-E alpha chain peptide 52–68 (Rees, Bender et al. 1999). We therefore 
used the lambda Red-mediated recombination system to insert the 2W peptide coding 
sequence at the 3’ end of the OmpC gene in the ST chromosome (Uzzau, Figueroa-Bossi 
et al. 2001). The resulting organisms, referred to hereafter as ST-2W, express an OmpC-
2W fusion protein (Fig. 6A). As shown in Fig. 6B, oral inoculation of ST-2W bacteria 
into Nramp1R 129 mice resulted in an infection that peaked between 2-3 weeks in the 
mesenteric lymph nodes (MLN) and spleen, then declined to an undetectable level in the 
spleen by day 50 but persisted at low levels in MLN for hundreds of days as previously 
described by Monack and colleagues for wild-type ST organisms (Monack, Bouley et al. 
2004). Therefore, ST-2W organisms were capable of producing a persistent infection that 
was controlled by CD4+ T cells.  
 
The CD4+ T cell response to intragastric ST-2W infection 
We next measured the number of 2W:I-Ab-specific cells over time after infection 
using a p:MHCII tetramer-based cell enrichment approach (Moon, Chu et al. 2009). Cells 
from MLN and spleens of infected 129 mice were stained with fluorochrome-labeled 
2W:I-Ab tetramer and anti-fluorochrome-labeled magnetic beads and enriched on 
magnetized columns as previously described (Moon, Chu et al. 2007). 2W:I-Ab tetramer-
binding cells were detected by flow cytometry among the CD4+ cells that bound to the 
column. 
Uninfected 129 mice each contained about 100 2W:I-Ab-specific CD4+ T cells in 
MLN and about 300 in spleen. The majority of the cells in both locations were CD44low 
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as expected for naïve T cells (Fig. 7A). A similar number and phenotype of 2W:I-Ab-
specific CD4+ T cells was observed in these tissues in 129 mice infected with ST 
organisms, not expressing the 2W peptide (Fig. 7A). In contrast, 2W:I-Ab-specific CD4+ 
T cells increased dramatically in number and CD44 expression in MLN and spleen after 
ST-2W infection (Fig. 7A). 2W:I-Ab-specific T cells present on day 6 and 60 after ST-
2W infection expressed large amounts of CD44 (Fig. 7A) and the Th1 lineage-defining 
transcription factor T-bet (Fig. 7B). Therefore, intragastric ST-2W infection of NrampR 
mice induced an early homogeneous Th1 population, some of which survived into the 
persistent phase of the infection. 
 
Salmonella p:MHCII-specific CD4+ T cells are numerically stable during persistent 
infection 
We next studied the kinetics of 2W:I-Ab-specific T cells following intragastric 
infection of 129 mice to determine whether a stable cell population was produced. The 
naïve 2W:I-Ab-specific CD4+ T cell population of about 400 cells proliferated to produce 
3x105 cells in MLN and 2x106 cells in the spleen two weeks after infection (Fig. 7C). The 
number of cells in both locations then underwent an 80% reduction that stabilized around 
day 40. Thereafter, the number of the 2W:I-Ab-specific CD4+ T cells remained consistent 
at 3x104 cells in MLN and 3x105 cells in the spleen. The cells in both locations were 
CD44high T-bethigh cells (Fig. 7B). These results show that ST p:MHCII-specific memory-
phenotype cells are stably maintained during persistent ST infection.  
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A BrdU-labeling experiment was then performed to determine whether 
proliferation within chronically infected tissues could account for CD4+ T cell stability 
during the persistent phase of infection. 129 mice were injected with BrdU on day 50 
after ST-2W infection, when viable bacteria were detected only in the MLN (Fig. 6B), 
and lymphoid organs were analyzed for BrdU incorporation 12 hours later as a measure 
of cellular proliferation. This short labeling period was chosen to maximize the chance 
that cells were labeled in the location where they divided. As shown in Fig. 8B, 5-10% of 
the 2W:I-Ab-specific CD4+ T cells located in the MLN labeled with BrdU, whereas only 
2-3% of cells in the spleen were labeled. Therefore, the stability of the 2W:I-Ab-specific 
population correlated with a higher rate of proliferation in the persistently infected MLN.  
 
CD4+ T cell maintenance is dependent upon persistent p:MHCII presentation 
If the 2W:I-Ab-specific population was maintained by proliferation of a subset of 
cells in persistently infected MLN, then clearance of the ST-2W bacteria would be 
expected to result in decline of the population. ST-2W-infected mice were cleared of 
infection by treatment with enrofloxacin antibiotic for 40 days, beginning at day 28 after 
ST-2W infection, as a test of this hypothesis. As shown in Fig. 9B, mice not treated with 
antibiotic had about twice as many 2W:I-Ab-specific T cells in their lymphoid organs on 
day 68 of ST-2W infection as mice that were treated with antibiotic.  
We next determined whether p:MHCII recognition was the aspect of persistent 
infection that was required for the stability of the 2W:I-Ab-specific population. CFSE 
labeled 2W:I-Ab-specific cells from the spleens and lymph nodes of persistently infected 
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(CD45.1 x 129) F1 mice were transferred into (B6 x 129) F1 mice with time-matched ST-
2W or wild-type ST infections. The number of donor-derived CD45.1+ 2W:I-Ab+ CD4+ T 
cells was enumerated 1, 7, or 50 days after transfer to assess the stability of the 
transferred cells. ST-2W bacteria were not transferred along with the T cells, as 
evidenced by the fact that the 2W:I-Ab-specific cells of endogenous origin in wild-type 
ST-infected mice, receiving 2W:I-Ab-specific memory-phenotype cells, neither 
proliferated nor increased CD44 expression (Fig. 9C). As shown in Fig. 9D, the numbers 
of transferred 2W:I-Ab-specific cells were similar between days 7 and 50 in ST-2W-
infected hosts, but were significantly lower on day 50 than on day 7 in hosts infected with 
wild-type ST bacteria lacking the 2W peptide.  
The stability of 2W:I-Ab-specific cells in ST-2W-infected hosts was associated 
with proliferation. 2W:I-Ab-specific cells residing in ST-2W- or wild-type ST-infected 
hosts for 50 days underwent 1-3 divisions, probably in response to IL-15 (Pepper, 
Linehan et al. 2010). However, donor-derived 2W:I-Ab-specific cells that resided in ST-
2W infected hosts for 50 days also contained cells that had divided greater than 7 times. 
Even though these cells accounted for 70% of the population 50 days after transfer, the 
fact they doubled at least 7 times during that period means they arose from less than 1% 
of the initial transferred population. These results are consistent with the possibility that 
periodic proliferation by a small number of cells in persistently infected MLN accounted 
for the long-term numerical stability of the 2W:I-Ab-specific cell population.  
 
ST-2W induced Th1 cells are multifunctional 
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We then investigated whether persistent ST-2W infection affected the function of 
2W:I-Ab-specific T cells. Mice infected with ST-2W 14, 45, or 100 days earlier were 
injected intravenously with 100 µg of 2W peptide to elicit lymphokine production by 
2W:I-Ab-specific T cells, which was detected by direct ex vivo intracellular staining. 
2W:I-Ab-specific T cells increased CD69 following 2W peptide injection and produced 
IFN-γ as expected based on their high expression of T-bet. While IFN-γ is essential for 
controlling persistent ST infection (Monack, Bouley et al. 2004), the best correlates of a 
protective Th1 response for other infections are CD4+ T cells capable of simultaneously 
producing IFN-γ, TNF, and IL-2 (triple+) (Darrah, Patel et al. 2007, Lindenstrom, Agger 
et al. 2009). Interestingly, almost all of the 2W:I-Ab-specific cells also expressed TNF 
and a fraction of these cells also produced IL-2 (Fig. 10A). Thus, 2W:I-Ab-specific T 
cells were maintained in a highly multifunctional state during persistent ST-2W infection. 
 
Antigen abundance affects CD4+ T cell function 
We next tested whether the low-level, localized p:MHCII presentation in the 
MLN of ST-2W infected mice that maintains CD4+ T cell numbers also preserved their 
function. We found that the overall composition of single (IFN-γ+), double (IFN-γ+, 
TNF+) and triple lymphokine-producing (IFN-γ+, TNF+, and IL-2+) cells was similar 
between donor-derived cells that resided for 50 days in ST-2W infected or uninfected 
hosts (Fig. 11C). These results indicate that periodic stimulation by 2W:I-Ab complexes 
during the persistent phase of infection did not significantly affect the cytokine 
production potential of the 2W:I-Ab-specific cells. 
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 This result was surprising in light of studies indicating persistent stimulation by 
p:MHCI complexes results in functional exhaustion of CD8+ T cells (Virgin, Wherry et 
al. 2009). It was possible that 2W:I-Ab-specific cells avoided exhaustion in mice with 
persistent ST-2W infection because infected antigen presenting cells were too rare. We 
tested this possibility by assessing the fate of 2W:I-Ab-specific memory-phenotype cells 
after transfer into (Act-2W x 129) F1 transgenic mice that display 2W:I-Ab throughout the 
body due to ubiquitous expression of 2W peptide under the control of the Actb promoter 
(Moon, Dash et al. 2011). Indeed, 2W:I-Ab-specific cells induced by ST-2W infection 
completely lost the capacity to produce lymphokines in response to peptide challenge 
after transfer and residence for 50 days in ST-2W-infected (Act-2W x 129) F1 transgenic 
mice. This loss of function was accompanied by induction of surface PD-1, which is a 
marker of T cell exhaustion (Fig. 11A) (Barber, Wherry et al. 2005). Therefore, 2W:I-Ab-
specific cells became functionally exhausted when exposed to systemic 2W:I-Ab 
complexes. 
 
4.3 Discussion 
Previous studies of acute L. monocytogenes and LCMV infections reached the 
conclusion that p:MHCII-specific CD4+ memory-phenotype T cells slowly decline after 
infections are cleared (Homann, Teyton et al. 2001, Pepper, Linehan et al. 2010). The 
numerical decline of murine CD4+ memory-phenotype T cells without their relevant 
antigen is at odds with the remarkable stability of CD8+ memory-phenotype T cells, IgM+ 
memory B cells and plasma cells (Slifka, Antia et al. 1998, Homann, Teyton et al. 2001, 
  57 
Pape, Taylor et al. 2011), and challenges the classical definition of immune memory. The 
stability of the population of 2W:I-Ab-specific T cells in mice with persistent ST-2W 
infection could result from the periodic proliferation of a few memory-phenotype CD4+ T 
cells to produce short-lived effector cells coupled with the slow death of non-stimulated 
memory-phenotype cells. Numerical stability would be achieved in this case despite the 
fact that neither the short-lived effector cells nor the quiescent memory-phenotype cells 
are perfectly stable. A similar scenario has been reported for CD8+ T cells induced by 
chronic LCMV infection (Shin, Blackburn et al. 2007). 
 The numerical decline of CD4+ memory-phenotype T cells without p:MHCII 
presentation may be less surprising when considering the relationship between immune 
memory and protection. Immune memory is useful to the host only insofar as it 
contributes to immune protection. CD4+ T cells are not essential for immunity to acute L. 
monocytogenes and LCMV infections, which are controlled by CD8+ T cells specific for 
abundant p:MHCI ligands generated by these cytosolic intracellular microbes 
(Matloubian, Concepcion et al. 1994, Portnoy, Auerbuch et al. 2002). Thus, the decline of 
CD4+ T cells comes at no cost to the host in these cases because these cells do not 
provide a protective advantage. In contrast, in a case where CD4+ T cells play an 
essential role in controlling a persistent phagosomal ST infection, p:MHCII-specific 
CD4+ memory-phenotype T cells were numerically stable. The fact that this stability 
depended on persistent infection and p:MHCII presentation indicates TCR stimulation is 
the key signal needed for maintenance of CD4+ T cells. Therefore, the classical idea of 
memory cell stability without antigen does not have to apply to CD4+ T cells in cases 
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where they are protective because the phagosomal infections that they control are 
persistent, thus providing a “constant TCR reminder” to maintain the T cell population.  
In the cases of chronic LCMV, hepatitis C, and HIV infections, prolonged 
p:MHCI antigen stimulation eventually results in the exhaustion of CD8+ T cells (Shin 
and Wherry 2007). The fact that persistent ST-2W infection and p:MHCII presentation 
was required to maintain CD4+ T cells without exhaustion is probably related to the low 
level of peptide:MHCII antigen presentation during persistent ST infection. This is 
supported by the recent demonstration of CD8+ T cell function in the face of chronic 
HSV infection in the sensory ganglia (Mackay, Wakim et al. 2012). The restricted 
anatomical location of infection could also influence CD4+ T cell function during 
persistent ST infection. After the first two months after oral ST infection, the MLN were 
the primary site in the body to harbor viable bacteria. Thus, it is conceivable that CD4+ T 
cells periodically migrate into sites of low-level persistent infection, proliferate in 
response to p:MHCII ligands displayed by persistently infected phagocytes, and then 
migrate to other body sites to recover. This process could produce numerical stability by 
balancing the death of cells in the population and prevent the cells from becoming 
exhausted. These ideas are supported by our observations that MLN were preferential 
sites of CD4+ T cell proliferation in persistently infected mice and exposure to systemic 
p:MHCII complexes resulted in CD4+ T cells that could not produce lymphokines and 
expressed high levels of PD-1, the canonical marker for exhausted cells (Shin and 
Wherry 2007). Thus, although the lack of cytokine production by these cells could be due 
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to an indirect mechanism like regulatory T cell suppression, it more likely relates to the 
direct mechanism of T cell exhaustion.  
Persistent low-level p:MHCII presentation by phagocytes during ST infection was 
also associated with homogenous production of Th1 cells, unlike transient p:MHCII 
presentation during acute infections, which generate a mixture of Th1 cells and follicular 
helper cells (Marshall, Chandele et al. 2011, Pepper, Pagán et al. 2011). The reason that 
follicular helper cells were not maintained during persistent ST infection could relate to 
lack of p:MHCII presentation by B cells (Johnston, Poholek et al. 2009).  
 Given the impressive lymphokine production capacity of 2W:I-Ab-specific cells 
in the face of persistent ST-2W infection, it was possible that periodic TCR stimulation 
was actually required to maintain multifunctional Th1 cells with maximal IFN-γ 
production. However, our results demonstrate that T-bet expression and IFN-γ production 
capacity was maintained at a high level in CD4+ memory-phenotype T cells that were 
parked in antigen-free hosts. However, a loss in the number of highly functional Th1 cells 
would be expected to reduce the capacity of CD4+ T cells to control a subsequent 
phagosomal ST infection. Such a loss could explain the concomitant immunity 
phenomenon studied in Leishmania-infected individuals. In this case, IFN-γ producing 
Th1 cells control the infection within phagocytes at the initial site of infection and 
prevent it from spreading to other parts of the body. Oddly however, the Th1 cells never 
eliminate the microbes from the initial site. Indeed, persistent infection at the original site 
is required for the Th1 cells to eliminate bacteria from other body sites after a second 
infection (Belkaid, Piccirillo et al. 2002). Our results indicate that localized persistent 
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infection and p:MHCII presentation is required to maintain a numerically stable CD4+ T 
cell population with maximal IFN-γ production capacity needed to control the infection at 
the initial site and eliminate it from other sites.  
 The fact that CD4+ T cells control persistent ST infection in phagocytes and 
presumably depend on p:MHCII presentation by these cells to be maintained as 
maximally functional cells and yet cannot eliminate the infection, is perplexing. One 
possibility is regulatory T cells within MLN restrain microbicidal activities of CD4+ 
effector T cells in the same location (McLachlan, Catron et al. 2009, Johanns, Ertelt et al. 
2010). Alternatively, persistently infected phagocytes may produce IL-10, which can 
ameliorate some of the phagocyte-activating effects of IFN-γ made by CD4+ T cells 
engaging in cognate interactions.  
 Our results suggest that a CD4+ T cell-dependent vaccine for a phagosomal 
pathogen will have to produce a local and long-lasting depot of bacterial antigen to 
maintain the protective CD4+ T cell population, which would otherwise decline. The 
failure to maintain protective CD4+ T cells could explain why the effectiveness of the 
Bacillus Calmette-Guérin vaccine against tuberculosis wanes after the vaccine organisms 
are cleared from the body. To improve on this situation, it may be necessary to produce 
even longer-lasting antigen delivery systems, perhaps along the lines of those used for 
long term administration of contraceptives. 
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Figure 6. Intragastric ST-2W infection is controlled by CD4+ T cells and persists in 
the MLN 
(A) Western blot of ST bacteria genomically tagged to express the 2W epitope on outer 
membrane porin C (OmpC) (42kDa). Wild-type ST bacteria do not express this peptide 
and are shown as a negative control. BAP is a FLAG-fusion protein of 47 kDa that served 
as a positive control. (B) ST-2W bacterial CFUs in the MLN (filled circles) or spleens 
(open circles) of mice with horizontal bars for mean values at the indicated times after 
intragastric ST-2W infection.  
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Figure 7. ST-2W infection induces a stable population of 2W:I-Ab-specific T cells 
(A) Plots of CD4+ T cells from uninfected (left) or at day 21 after ST (middle) or ST-2W 
(right) infection in 129 mice. The percentages of 2W:I-Ab+ cells in the tetramer-enriched 
populations are shown. (B) Histograms showing T-bet on naïve CD4+ CD44low cells 
(filled gray) or 2W:I-Ab-specific CD44high T cells (black line) from the MLN (top) and 
spleens (bottom) of mice at the indicated times after intragastric infection with ST-2W 
bacteria. (C) Mean ± SEM (n ≥ 3 for each time point) of 2W:I-Ab+ T cells in the spleens 
(filled circles) and MLN (open circles) over the first 552 days after intragastric infection 
with ST-2W bacteria. 
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Figure 8. CD4+ T cell proliferation occurs at the site of persistent infection  
(A) BrdU labeling of 2W:I-Ab-specific T cells in the MLN (left) and spleen (right) of 
mice injected 12 hours earlier with 1 mg of BrdU 50 days after intragastric infection with 
ST-2W bacteria. (B) Percentage of BrdU+ 2W:I-Ab-specific T cells in the MLN (filled 
circles) and spleens (open circles) of mice infected with ST-2W bacteria. Each symbol 
represents an individual mouse and horizontal line indicates the mean. 
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Figure 9. Numerical stability of CD4+ T cells is dependent on p:MHCII-induced 
proliferation  
(A) Plots of CD4+ T cells at day 68 after ST-2W infection from untreated mice (top) or 
mice that were treated with enrofloxacin for 40 days beginning at day 28 post-infection 
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(bottom). (B) Number of 2W:I-Ab-specific cells in spleen and lymph nodes at day 68 
after ST-2W infection in untreated (filled circles) or enrofloxacin-treated (open circles) 
mice. (C) CD4+ T cells from ST-2W immune mice were transferred into ST-2W (left) or 
ST (right) infection-matched hosts 50-75 days post-infection. Plots of 2W:I-Ab-enriched 
CD4+ T cells 1 day (top) or 50 days (bottom) after transfer. Gates indicate donor- 
(CD45.1+) or host-derived (CD45.1-) 2W:I-Ab+ cells. Day 50 gates indicate frequency of 
CFSE fully (left gate) or partially (right gate) diluted, donor-derived (CD45.1+) 2W:I-Ab-
specific cells. (D) Frequency of donor-derived 2W:I-Ab-specific cells at 7 or 50 days after 
transfer into ST-2W (filled circles) or ST (open circles) infection-matched hosts, 
normalized for day 1 park rates in independent experiments. P values are from a 
comparison of day 7 and day 50 values from the ST-2W- or ST-infected recipients. (E) 
Number of CFSE fully diluted, donor-derived (CD45.1+) 2W:I-Ab-specific cells at 50 
days after transfer into ST-2W (filled circles) or ST (open circles) infection matched 
hosts. 
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Figure 10. ST-2W infection induces multifunctional Th1 cells  
(A) Histograms showing intracellular IL-2 (left) in 2W:I-Ab-specific cells and contour 
plots of TNF versus IFN-γ of IL-2- (middle) and IL-2+ (right) cells from the MLN 2 hrs 
after intravenous injection of 2W peptide at 14 (top), 45 (middle), or 90 (bottom) days 
after intragastric ST-2W infection. The shaded histogram shows intracellular IL-2 in 
2W:I-Ab-specific cells from mice that were not injected with 2W peptide. The day 14 and 
45 experiments were collected on the flow cytometer on the same day, while the day 90 
experiment was run on a different day. The quadrants were set on each day on CD44low, 
2W:I-Ab- cells, which do not produce cytokines. (B) Percentages of single+ (IFN-γ+), 
double+ (IFN-γ+, TNF+) triple+ (IFN-γ+, TNF+, and IL-2+), and triple- (IFN-γ-, TNF-, and 
IL-2-) lymphokine-producing 2W:I-Ab-specific cells in the MLN (left) and spleens 
(right), 2 hrs after intravenous injection of 2W peptide at the indicated days after ST-2W 
infection. 
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Figure 11. Function of CD4+ memory-phenotype T cells is dependent upon antigen 
abundance 
(A) Plots of CD45.1 versus 2W:I-Ab tetramer (left) or histograms of PD-1 expression by 
CD45.1+ 2W:I-Ab+ donor-derived cells (right) 50 days after transfer into ST-2W 
infection-matched (B6 x 129) F1 hosts (top), uninfected (B6 x 129) F1 hosts (middle), or 
ST-2W infection-matched (Act-2W x 129) F1 transgenic hosts (bottom). (B) Histograms 
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showing intracellular IFN-γ, TNF, or IL-2 expression in donor-derived (CD45.1+) 2W:I-
Ab-specific cells 50 days after transfer into ST-2W infection-matched (B6 x 129) F1 
(black line), uninfected (B6 x 129) F1 (dotted line), or ST-2W infection-matched (Act-2W 
x 129) F1 hosts (gray), before (top) or 2 hr after (bottom) intravenous injection of 2W 
peptide. (C) Percentages of single+ (IFN-γ+), double+ (IFN-γ+, TNF+) triple+ (IFN-γ+, 
TNF+, and IL-2+), and triple- (IFN-γ-, TNF-, and IL-2-) lymphokine-producing donor-
derived (CD45.1+) 2W:I-Ab-specific cells 50 days after transfer into ST-2W infection-
matched (B6 x 129) F1, uninfected (B6 x 129) F1, or ST-2W infection-matched (Act-2W x 
129) F1 transgenic hosts, 2 hrs after intravenous injection of 2W peptide. Horizontal bars 
indicate mean values. 
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Chapter 5 
 
A large population of CD4+ T cells specific for a single p:MHCII plays a large role 
in control of Salmonella enterica infection 
 
5.1 Introduction 
 The relationship between naïve T cell population size and the response to 
immunization has brought new insight to understanding immunodominance. The 
important role for large naive p:MHCI-specific CD8+ T cell populations in controlling 
viral infections is now clear. For example, overlapping peptide libraries encompassing 
the entire proteome of LCMV have led to a comprehensive assessment of the LCMV-
peptide:MHCI-specific CD8+ T cell responses in mice. Interestingly, of 28 identified 
LCMVp:Db-specific CD8+ T cell responses, the 3 largest naïve cell populations 
accounted for almost one third of the total CD8+ T cell response to LCMV infection, 
whereas the 18 smallest naïve cell populations accounted for a very small percentage 
(Kotturi, Scott et al. 2008). Furthermore, vaccinating mice with individual peptides 
recognized by naive CD8+ T cell populations consisting of 100 cells or more protected 
mice against LCMV challenge (van der Most, Murali-Krishna et al. 1998, Kotturi, Peters 
et al. 2007, Kotturi, Scott et al. 2008). 
However, whether a large population of CD4+ T cells specific for a single 
bacterial peptide can have a meaningful impact on protecting the host from bacterial 
infection is unknown. Salmonella enterica is a facultative intracellular pathogen that is 
  73 
controlled by IFN-γ-producing CD4+ T cells (de Jong, Altare et al. 1998, Monack, 
Bouley et al. 2004). In mice, S. enterica serovar Typhimurium (ST) causes a persistent 
infection similar to typhoid fever in humans. To determine whether a single large 
p:MHCII-specific CD4+ T cell population could influence the control of persistent ST 
infection, we studied the responses to infection with either wild type ST or recombinant 
ST expressing the 2W peptide (ST-2W). There was a significantly lower bacterial burden 
in ST-2W infected mice as compared to paired ST infection. By comparing this outcome 
to mice that could not respond to 2W:I-Ab but could respond to all other ST expressed 
peptides, it was determined that this effect was due to the large response to 2W:I-Ab.  
 
5.2 Results 
 
The 2W:I-Ab-specific response to ST-2W infection accounts for a large fraction of 
the total CD4+ T cell response 
 The 2W variant of MHCII I-E alpha chain peptide 52–68 (Rees, Bender et al. 1999) 
is a foreign peptide in B6 and 129 mice, which binds to the MHCII molecule I-Ab and is 
recognized by a large population of approximately 300 naïve CD4+ T cells. This large 
naïve population is in contrast to the small populations of 20 or fewer cells that 
recognizing known ST-encoded p:I-Ab ligands FliC and SseJ (Moon, Chu et al. 2007, 
Lee, McLachlan et al. 2012). This prompted the question of what proportion of the 
protective IFN-γ-producing CD4+ T cell response to ST-2W infection can be attributed to 
300 naïve CD4+ T cells specific for 2W:I-Ab. Considering Salmonella expresses 
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approximately 4,000 foreign proteins and many would contain multiple I-Ab binding 
peptides, we hypothesized that 2W:I-Ab-specific response would comprise at most 1% of 
the total IFN-γ response to ST-2W despite its large naïve population. To test this, we 
immunized 129 mice by oral inoculation with 108 ST-2W organisms re-stimulated CD4+ 
T cells in the spleen and mesenteric lymph nodes with the non-specific TCR mimics 
PMA and ionomycin. As shown in Figure 12A, the 2W:I-Ab-specific response accounted 
for between 10-30 percent of the total number of IFN-γ producing cells.  
 
The response to a single p:MHCII lowers the bacterial load during persistent ST 
infection 
The surprising frequency of IFN-γ producing that were specific for a single 
p:MHCII ligand lent itself to the possibility that this could be affecting immunity. A clue 
that this may be the case was that the bacterial load detected in mice infected with ST-2W 
(Nelson, McLachlan et al. 2013) was lower than originally described for infection with 
the ST strain used to generate ST-2W (Monack, Bouley et al. 2004). It was previously 
assumed that the most likely explanation for this discrepancy was that insertion of the 2W 
peptide on the C-terminal end of the essential outer membrane protein OmpC affected the 
fitness of the bacteria. To test these two non-mutually exclusive possibilities, we infected 
(B6 x 129) F1 and (Act-2W x 129) F1 mice with either ST or ST-2W and determined the 
number of bacterial CFUs 50 days later. The presence of 2W as a self peptide in Act-2W 
mice leads to complete tolerance of 2W:I-Ab-reactive cells (Moon, Dash et al. 2011). To 
our surprise, we found significantly higher ST-2W CFUs in (Act-2W x 129) F1 mice than 
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(B6 x 129) F1 mice (Figure 12B). In contrast, there was no difference between (B6 x 129) 
F1 mice and (Act-2W x 129) F1 mice in controlling the control ST infection. It should also 
be noted there were still more ST bacteria than ST-2W bacteria in either mouse strain, 
suggesting that the epitope tag also affected the survival of the bacteria. Nevertheless, 
this result demonstrates that a large population of CD4+ T cells specific for a single 
p:MHCII plays a large role in control of Salmonella enterica infection. 
 
5.3 Discussion 
 The fact that the 300 naïve cells specific for 2W:I-Ab could produce 30% of the 
total response to infection with a complex bacterial pathogen highlights importance of 
identifying large naïve CD4+ T cell populations. This result also demonstrates how large 
naïve populations are relatively rare in the pre-immune repertoire, which could explain 
the paucity of immunodominant epitopes that have been described for these pathogens. 
Therefore, an improved understanding of the factors that shape naïve T cell population 
size is necessary to identify the key targets for subunit vaccines. 
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Figure 12. The response of a single large CD4+ T cell population affects the bacterial 
load during persistent ST infection.  
(A) Plots indicating the percentage of IFN-γ-producing cells CD4+ T cells by intracellular 
cytokine staining after PMA and ionomycin re-stimulation (left) and downstream gate 
showing frequency of IFN-γ+ cells that are 2W:I-Ab+ after ST-2W infection. 
  77 
(B) ST-2W bacterial CFUs (filled circles, left) or ST bacterial CFUs (open circles, right) 
in the MLN of (B6 x 129) F1 or (Act-2W x 129) F1 mice, 50 days after oral infection. 
Horizontal bars indicate mean values. 
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Chapter 6 
 
Conclusions 
 
The latter half of my thesis research, presented in chapter 3, sought to understand 
fundamental principles of TCR recognition of p:MHCII ligands to determine if general 
rules could be established to predict what peptides will elicit large CD4+ T cell responses. 
The result of these efforts was generation of a very simple model: the majority of what a 
T cell “sees” are those amino acids in a peptide that protrude out of the MHC binding 
groove and can contact the TCR. This rule did not have to be true, as we also found 
evidence that the amino acids that anchor the peptide in the MHCII groove can lead to 
different conformations of the TCR contact amino acids, and some TCRs can detect these 
differences. However, the general model was very recently substantiated by the work of 
Garcia and colleagues, when they developed technology to screen an estimated 108 
p:MHCII complexes against TCRs with known p:MHCII ligands to determine breadth of 
cross-reactive of MHCII-bound peptides an individual TCR could see (Birnbaum, 
Mendoza et al. 2014). This group came up with a very similar rule: TCR contact amino 
acid identity with a known peptide ligand is the simplest way to predict if a second 
MHCII-bound peptide will be able to bind the same TCR. The fact that this result was 
achieved in an independent assay for two different MHCII allelomorphs suggests that this 
rule could be applied broadly.  
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We were specifically interested in determining why naïve CD4+ T cell 
populations specific for foreign peptides bound to the mouse MHCII molecule I-Ab 
varied over two orders of magnitude in size. We hypothesized that since none of the 
foreign peptides we tested shared all 9 core amino acids with mouse self peptides, 
negative selection on foreign p:MHCII-specific cell populations must be based upon TCR 
cross-reactivity with non-identical self peptides. Using the rule that amino acid identity at 
at least 4 out of 5 TCR contact amino acids at P2, 3, 5, 7, and 8 was necessary to predict 
TCR cross-reactivity, we found an inverse correlation between the naïve population size 
of 21 foreign p:MHCII-specific CD4+ T cell populations and the number of I-Ab binding 
homologous mouse peptides. These results shed some light onto the findings of Moon et 
al. (Moon, Chu et al. 2007), who developed the p:MHCII tetramer-based cell enrichment 
strategy to perform the first in-depth analysis of the pre-immune CD4+ T cell repertoire 
and its effects on immune responses. 
Chapter 4 addressed a separate but related issue – how does a large CD4+ T cell 
population behave during infection (Pepper, Linehan et al. 2010). As the issue of CD4+ T 
cell stability had not been addressed for a persistent bacterial infection where CD4+ T 
cells are the protective cell type, we studied p:MHCII-specific response to persistent 
Salmonella infection. Our results demonstrated that the CD4+ T cell response to a 
Salmonella peptide:MHCII was numerically and functionally stable for as long as the 
bacteria persisted. This stability was associated with peptide:MHCII-driven proliferation 
by a small number of T cells in the secondary lymphoid organs harboring bacteria. This 
  80 
work is significant because it could explain why current vaccines targeting Salmonella or 
Mycobacterium tuberculosis wane in efficacy after antigen is cleared.  
In chapter 5, the impact of a large population of CD4+ T cells specific for a single 
p:MHCII was assessed. Remarkably, one large foreign p:MHCII-specific T cell 
population played a large role in controlling ST infection, despite the likely presentation 
of many other ST-derived p:MHCII. Putting these findings together, one could envision a 
day where immunologists are successfully able to predict immunodominant epitopes 
based solely upon knowledge of a bacterial proteome and an individual’s HLA type, then 
develop a safe and efficacious subunit vaccine that produces long lasting CD4+ T cell-
mediated protection by long term delivery of antigen. 
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